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ABSTRACT
Capacitive bioaffinity detection using microelectrodes is considered as a
promising label-free method for point-of-care diagnosis, though with challenges
in sensitivity, specificity and the time “from sample to result.” This work presents
an alternating current (AC)-electrokinetic based capacitive affinity sensing
method that is capable of realizing rapid in-situ detection of specific
biomolecular interactions such as probe-analyte binding. The capacitive
biosensor presented here employs elevated AC potentials at a fixed frequency
for impedimetric interrogation of the microelectrodes. Such an AC signal is
capable of inducing dielectrophoresis (DEP) and AC electrothermal (ACET)
effects, so as to realize in-situ enrichment of macro and even small molecules
at microelectrodes and hence accelerated detection. Experimental study of the
DEP/ACET-enhanced capacitive sensing method was conducted, and the
results corroborate our hypothesis.
This capacitive sensing method has been shown to work with various types
and sizes of biomolecules (such as antibodies, virus and small molecules) to
differentiate disease-positive samples from negative samples within or less
than two minutes, while conventional assay would require multiple processing
steps and take hours to complete. The results showed high accuracy and
sensitivity. Overall, this capacitive affinity biosensor may form a basis for the
development of a feasible point-of-care diagnostic platform for the detection of
infectious diseases in the future.

v

TABLE OF CONTENTS
Chapter 1 Introduction................................................................... 1
1.1 Biosensor: its future in your health and well-being ................................. 1
1.2 Biosensor: its major challenges .............................................................. 3
1.3 Dissertation Outline ................................................................................ 5

Chapter 2 Literature review of biosensors ..................................... 6
2.1 Various types of biosensors ................................................................... 6
2.1.1 Optical Biosensors............................................................................................. 6
2.1.1.1 Fluorescent biosensors ................................................................................... 7
2.1.1.2 Surface Plasmon Resonance (SPR) biosensors ............................................ 8
2.1.1.3 Chemiluminescence (CL) biosensors ............................................................. 9

2.1.2 Electrochemical biosensors............................................................................. 10
2.1.2.1 Amperometric biosensors ............................................................................. 10
2.1.2.2 Potentiometric biosensors .............................................................................. 11
2.1.2.3 Impedimetric biosensors ............................................................................... 12

2.1.3 Piezoelectric biosensors .................................................................................. 13
2.1.4 Magnetic biosensors........................................................................................ 14

2.2 Comparison of different biosensing techniques .................................... 16
2.3 Affinity-based biosensing ..................................................................... 17
2.3.1 Important metrics ............................................................................................. 17
2.3.2 Detection: label vs label-free; end-point vs real-time [103] ............................. 18
2.3.3 Affinity biosensors: prospective ....................................................................... 19

Chapter 3 Basics of capacitive sensing ....................................... 21
3.1 Electrochemical Impedance Spectroscopy (EIS).................................. 21
3.1.1 EIS introduction ............................................................................................... 21
3.1.2 Circuit network of electrode-fluid system ........................................................ 21

3.2 Direct capacitive biosensing ................................................................. 24
3.2.1 Electric double layer ........................................................................................ 24
3.2.2 Interfacial capacitance ..................................................................................... 26
3.2.3 Capabilities ...................................................................................................... 29

Chapter 4 Basics of AC electrokinetics ....................................... 30
4.1 The importance of inducing ACEK ....................................................... 30
4.2 ACEK for particle and fluid acceleration ............................................... 31
4.2.1 Dielectrophoresis (DEP) .................................................................................. 31
vi

4.2.2. AC electroosmosis (ACEO) and AC electrothermal (ACET) effect ................ 32
4.2.3 Order of magnitude comparison: ACEK forces vs. natural forces .................. 35

Chapter 5 Sensor Development .................................................. 37
5.1 Incorporation of direct capacitive sensing and ACEK ........................... 37
5.2 Device design ....................................................................................... 39
5.2.1 Preparation of microelectrode sensor ............................................................. 39
5.2.2 Test fixture and instrument setup .................................................................... 42

5.3 Assay methods ..................................................................................... 44
5.3.1 Electrode surface cleaning .............................................................................. 44
5.3.2 Surface functionalization ................................................................................. 47
5.3.2.1 Passive adsorption ........................................................................................ 47
5.3.2.2 Usage of linker molecules ............................................................................. 51
5.3.2.2.1 APTES treatment ........................................................................................ 52
5.3.2.2.2 Thiol mediation............................................................................................ 54

5.3.2.3 Comparison ................................................................................................... 56

5.3.3 Surface blocking .............................................................................................. 56
5.3.4 Analyte detection ............................................................................................. 57
5.3.5 Summary ......................................................................................................... 57

5.4 Sensor Characterization ....................................................................... 58
5.4.1 Extracting the values of circuit elements ......................................................... 58
5.4.2 Simplified equivalent circuit ............................................................................. 62

5.5. Conclusion........................................................................................... 63

Chapter 6 Results of analyte detection ........................................ 64
6.1 Sample and assay description.............................................................. 64
6.2 Bovine IgG antibody interaction............................................................ 65
6.2.1 Proof-of-concept .............................................................................................. 65
6.2.2 Impact of electrode design on detection ......................................................... 68
6.2.3 Impact of electric field strength........................................................................ 70
6.2.4 Determination of LOD ...................................................................................... 75

6.3 Detection of antibody in serum ............................................................. 75
6.3.1 Sample preparation ......................................................................................... 76
6.3.1.1 Johne’s disease antigen and serum samples ............................................... 76
6.3.1.2 Human and Bovine TB specific antigens and serum samples...................... 77

6.3.2 Proof-of-concept .............................................................................................. 78
6.3.3 Signal optimization .......................................................................................... 80
6.3.4 Detection results of serum samples ................................................................ 83
6.3.4.1 Johne’s disease ............................................................................................ 83
vii

6.3.4.2 Human and Bovine tuberculosis ................................................................... 84

6.4 Influenza A virus Detection ................................................................... 86
6.4.1 Sample preparation ......................................................................................... 87
6.4.2 Specificity......................................................................................................... 87
6.4.3 Effect of linker molecules................................................................................. 89
6.4.4 Blocking optimization ....................................................................................... 91
6.4.5 Blind test of clinical swab samples .................................................................. 92

6.5 Small molecule detection ...................................................................... 93
6.5.1 Sample preparation ......................................................................................... 95
6.5.1.1 Bisphenol A ................................................................................................... 95
6.5.1.2 Progesterone ................................................................................................. 95

6.5.2 Detection of BPA.............................................................................................. 96
6.5.2.1 Proof-of-concept............................................................................................ 97
6.5.2.2 Study of ACET effect ..................................................................................... 98
6.5.2.3 Determination of LOD ................................................................................. 100

6.5.3 Preliminary detection of PG........................................................................... 100

Chapter 7 Conclusions and Future Work................................... 102
7.1 Summary ............................................................................................ 102
7.2 Future Work........................................................................................ 103
7.2.1 Further improvement of feasibility ................................................................. 103
7.2.2 Multiplexed assay with high specificity .......................................................... 104
7.2.3 Handheld device ............................................................................................ 104

List of References ..................................................................... 105
Vita ............................................................................................ 125

viii

LIST OF TABLES
Table 1.1 Characteristics of a desired biosensor. ............................................ 3
Table 2.1 Advantages and disadvantages of different types of biosensors. .. 16
Table 4.1 Parameters involved in ACEK force calculation. ............................ 35
Table 5.1 Comparison between passive adsorption and linkers. ................... 56
Table 5.2 Equivalent circuit parameters obtained by curve-fitting the
experimental results for SAW electrodes. ............................................... 59
Table 5.3 Equivalent circuit parameters obtained by curve-fitting the
experimental results for gold electrodes. ................................................ 61
Table 5.4 Measured voltage drop on gold electrodes. ................................... 62
Table 6.1 Target analyte description. ............................................................. 64
Table 6.2 Assay description. .......................................................................... 65
Table 6.3 dC/dt (%/min) of 1 and 5ng/mL for every 10 seconds. ................... 74
Table 6.4 Repeatability test with bTB samples. Each sample is tested five
times on five different chips. ................................................................... 86
Table 6.5 Repeatability test with flu A virus. 1000 ng/mL virus sample is tested
five times on five different chips. ............................................................. 90
Table 6.6 Descriptions of various blocking methods and major conclusions. 92
Table 6.7 Blind test results of twenty clinical swab Influenza A samples. ...... 93
Table 6.8 Capacitance change rates within two different time periods. ......... 98

ix

LIST OF FIGURES

Figure 2.1 Fluorescence biosensor developed by previous members of our
group (a) Experimental setup. (b) Fluorescence images of immunoassay.
.................................................................................................................. 7
Figure 2.2 Schematic view of SPR immunoassay............................................ 8
Figure 2.3 Schematic view of CL detection. ..................................................... 9
Figure 2.4 Schematic view of a common three electrode system (left) and
actual device (right). ............................................................................... 11
Figure 2.5 An extended-gate FET biosensor for HAS antibody detection. ..... 12
Figure 2.6 Experimental apparatus of a typical piezoelectric biosensor. ........ 14
Figure 2.7 Schematic of immunocomplex labelling with a magnetic particle. . 15
Figure 2.8 A GMRS for the detection of the recognition between streptavidin
and biotin. ............................................................................................... 15
Figure 2.9 Basic components of affinity biosensor. ........................................ 17
Figure 2.10 An HRP labeled antibody conjugate. .......................................... 19
Figure 3.1 Circuit model of the electrode-fluid system. .................................. 22
Figure 3.2 Impedance spectrum of an electrode-fluid system. ....................... 23
Figure 3.3 Nyquist plot of an electrode-fluid system. ..................................... 24
Figure 3.4 Schematic diagram of EDL together with the variation in potential
with distance y from the surface. ............................................................ 25
Figure 3.5 Changes at the electrode surface due to the binding of specific
antibody to immobilized antigen.............................................................. 26
Figure 3.6 Two possible topology changes at the solid/fluid interface due to
protein binding reaction. (a) The thickness of the interfacial layer
increases while its surface area decreases, Cint reduces as a result; and
(b) when the increase in the surface area of Cint dominates over the
changes in its thickness, Cint increases. (Ab: antibody; Ag: antigen) ..... 28

x

Figure 4.1 Schematic illustration of DEP force: (a) positive DEP and (b)
negative DEP. ......................................................................................... 32
Figure 4.2 Schematic illustration of ACEO flow. ............................................ 33
Figure 4.3 Schematic illustration of ACET flow. ............................................. 34
Figure 5.1 Breaking the diffusion limit by inducing ACEK. ............................. 38
Figure 5.2 (a) Commercially available electrode chips, i.e. surface acoustic
wave (SAW) resonator chips (PARS 433.92, AVX Corp). The left one is
modified for immunosensing. (b) A scanning electron micrograph of the
microelectrode array in the SAW chip. .................................................... 40
Figure 5.3 (a) In-house fabricated gold microelectrodes on silicon wafer with a
silicone chamber on top of it; (b) SEM image of the interdigitated array
inside. ..................................................................................................... 40
Figure 5.4 Individual sensor after dicing (left: without chamber; right: with
chamber)................................................................................................. 41
Figure 5.5 Agilent 4294A with 16047E test fixture connected with a data
acquisition computer. .............................................................................. 43
Figure 5.6 Connection of SAW chip to the test fixture.................................... 43
Figure 5.7 Connection of gold chip to the test fixture. .................................... 44
Figure 5.8 Capacitance values with different washing methods. For each
condition, five chips are measured. ........................................................ 46
Figure 5.9 (a)-(e) Microscopic images of incubated electrodes. Left column
shows the actual image, right column shows the light intensity. . ........... 48
Figure 5.10 Different types of linker molecules. (a) APTES and (b) thioctic
acid. ........................................................................................................ 52
Figure 5.11 Schematic of APTES treatment of a substrate. ........................... 53
Figure 5.12 Comparison of capacitances between washed bare SAW
electrodes and APTES-treated SAW electrodes. Five chips are measured
and their capacitance values are plotted. ............................................... 54
Figure 5.13 Schematic of thiol SAM formation and activation with NHS+EDC.
................................................................................................................ 55
xi

Figure 5.14 Comparison of capacitances between washed bare gold
electrodes and thiol-mediated gold electrodes. Five chips are measured
and their capacitance values are plotted. ............................................... 55
Figure 5.15 Summary of assay procedure. .................................................... 57
Figure 5.16 Comparison of measured impedance spectra and curve fitting
using the four element equivalent circuit model of SAW electrodes.
(Frequency range: 10 kHz-1MHz. Signal applied: 5 mVrms.) ................. 59
Figure 5.17 Comparison of measured impedance spectra and curve fitting
using simplified Rf-Cint serial connection for SAW electrodes. (Frequency
range: 10 kHz-1MHz. Signal applied: 5 mVrms.) .................................... 60
Figure 5.18 Comparison of measured impedance spectra and curve fitting of
gold electrodes. (a) Using the four element equivalent circuit; (b) Using
Rf-Cint serial connection. (Frequency range: 100 Hz-1MHz. Signal
applied: 5 mVrms.).................................................................................. 61
Figure 6.1 Normalized capacitance change as a function of time within two
minutes for three different concentrations of bovine IgG antibody (10, 100
and 1000 ng/mL) in 0.1x PBS and 0.2x PBS respectively. The boxed-in
numbers in the figure are the fractional capacitance change rates of
different IgG concentrations. ................................................................... 67
Figure 6.2 Antibody binding responses from three different electrodes under
similar electric field strength. Each test is repeated three times. Error bar
indicates the standard deviation. Control results include both buffer and
non-specific binding on un-functionalized electrodes.............................. 69
Figure 6.3 Binding responses of control buffer, non-specific, 10 ng/mL and
100 ng/mL IgG samples under different electric field strengths. Both 2μm
and 5μm gold electrodes are tested for comparison. Each test is repeated
twice and the error bar indicates standard deviation. .............................. 71
Figure 6.4 Normalized capacitance change with time. (a) 2μm electrodes
measured at 86 mV/µm; (b) 5μm electrodes measured at 45 mV/µm; (c)
5μm electrodes measured at 86 mV/µm. ................................................ 73
xii

Figure 6.5 Transient behavior of normalized capacitances of JD serum
samples. The samples are various dilutions of JD positive sera (1:20 to
1:200), negative sera (1:20) and 0.1x PBS (control). .............................. 80
Figure 6.6 Capacitance change rates of JD positive serum sample and control
buffer (0.1X PBS) when they are tested at (a) 100 kHz AC signals of
various voltage amplitudes, (b) 100 mVrms AC signals at different
frequencies. Each data point shows the average of three tests. Error bar
indicates the standard deviation. ............................................................ 82
Figure 6.7 Detection results of Johne’s disease serum samples. .................. 83
Figure 6.8 Repeatability test with JD positive sample. Same positive sample is
tested five times on five different SAW electrodes. ................................. 84
Figure 6.9 Capacitive sensing vs. ELISA of human TB (hTB) positive and
negative serum samples. (P: positive samples, N: negative samples; C:
control buffer).......................................................................................... 85
Figure 6.10 Capacitive sensing vs. ELISA of bovine TB (bTB) positive and
negative serum samples from badgers. (P: positive samples, N: negative
samples; C: control buffer) ...................................................................... 85
Figure 6.11 Specificity test of Influenza A: four different scenarios. ............... 88
Figure 6.12 Capacitance change rates for the four scenarios under 10 and
100 mVrms. Each data point is the average of three repeated tests. Error
bar indicates standard deviation. ............................................................ 89
Figure 6.13 Flu A detection results: passive adsorption vs. thiol linker. Each
data point is the average of five repeated tests. Error bar indicates
standard deviation. ................................................................................. 91
Figure 6.14 Characteristic changes of interfacial capacitance with time when
different samples arew tested. Binding reactions with 1, 10, 100 and 1000
fM BPA are shown here. Buffer (blank without BPA) and non-specific
(1pM BPA sample tested on dummy electrodes) are shown as controls.
................................................................................................................ 98
xiii

Figure 6.15 BPA detection results on both electrodes. Buffer tests are 0.1x
PBS on functionalized electrodes; non-specific tests are 1-100 fM BPA on
dummy electrodes; specific tests use 1-100 fM BPA samples on
functionalized electrodes. Each data point is the average of three
repeated tests and the error bar indicates standard deviation. ............... 99
Figure 6.16 Detection results of progesterone binding. Different change rates
indicate different binding levels. Each test is repeated three times. Error
bar represents the standard deviation of three test results. .................. 101
Figure 7.1 Concept of a portable POC device. ............................................ 104

xiv

Chapter 1. Introduction
1.1 Biosensor: its future in your health and well-being
The spread and epidemic of infectious diseases have posed tremendous
burden to the whole world [1]. For example, human tuberculosis, caused by
Mycobacterium tuberculosis, occurs in more than ten million people worldwide,
and is estimated to be responsible for the death of two million people annually
[2]. For wildlife and livestock, diseases like Johne’s disease [3] and mastitis [4]
causes the reduction of milk production (in dairy cows), weight loss and
premature culling clinically affected animals. Particularly, mastitis causes an
estimated $1.7-2.0 billion USD annual economic loss to the US dairy industry.
Worldwide, it is the most costly disease affecting the dairy industry, incurring
economic losses estimated at $50 billion/year.
In the developing world, the situation is even worse [5]. Infectious diseases
are responsible for a massive death toll on the populations of developing
countries every year. According to World Health Organization (WHO), 21% of
childhood death in the Africa region is caused by pneumonia [6]; still in Africa,
more than 25% of infants are likely to acquire AIDS in the first year of life if their
mothers are infected with HIV [7]; moreover, diarrheal diseases are estimated
to cause around 2.5 million deaths among children under 5 years old, of which
more than 85% takes place in the world’s poorest places [8, 9].
In the face of such a harsh reality, organizations and nations are putting an
increasing number of manpower and material resources towards understanding
and negating the proliferation of infectious diseases [10-12]. Among all the
efforts, the production of low-cost while practical diagnostic devices is one of
the core tasks. Since only with appropriate diagnosis would we be able to
perform the necessary therapy. Nevertheless, current diagnostic tools have
fallen far behind the needs of the majority, especially in less developed areas.
1

For instance, most developing countries do not possess even half of the basic
medical tools needed for routine health care [13]. In other words, the inabilities
to provide practical low-cost devices for point-of-care diagnosis have limited the
access to proper test and treatment for those that need them most [14, 15].
Recently, National Academy of Engineering (NAE) has listed healthcare as
one of the grand challenges facing our global future. As of now, large
percentages of vulnerable population are still seeking improved quality of life,
which brings significant opportunity for technology to improve global health. For
example, hassle free and comfortable health monitoring systems are always
desired [16]; also, there is huge merging market space for disease diagnosis,
especially if it can be done in early stage.
As an integral and crucial part of all health services, point-of-care diagnosis
tool stands out as a promising future in preventing or minimizing the spread of
a virus or disease outbreak. Point-of-care diagnosis refers to the action of
conducting simple and quick medical testing or treatment at the site of patient,
which is usually accomplished by portable/handheld devices [17, 18]. In this
regard, one attractive tool that is capable of providing instant information on a
disease outbreak is biosensor [19]. Biosensor is a device designed to detect or
quantify a specific biomolecule such as protein or DNA. It is well established
that biosensors can be applied in various fields, including medical science [2022], food and water inspection [23-26], environment surveillance [27] and crop
protection [28, 29]. In principle, biosensors offer the possibility of real-time
monitoring, and the deployment of these devices in the field would provide a
low-cost and rapid detection of diseases. A desired biosensor possesses some
general characteristics, as provided by WHO in Table 1.1 [5].
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Table 1.1 Characteristics of a desired biosensor.
Affordable by those at risk of infection.
Sensitive (few false-negative results).
Specific (few false-positive results).
User-friendly (simple to perform by persons with little training).
Rapid treatment at the first visit and robust use without the need for
special storage.
Equipment-free (that is, no large electricity dependent instruments
needed to perform the test.
Delivered to those who need it.

In addition, a medically relevant biosensor is highly desired to be able to
realize more advanced functions such as multiplex sensing and intelligent data
acquisition. As we can imagine, biosensors with aforementioned characteristics
will have a giant impact on lifestyle related outcomes of infectious diseases.

1.2 Biosensor: its major challenges
Broadly speaking, there are two major types of biosensors: catalytic
biosensor and affinity biosensor [30]. Catalytic biosensors measure the change
in the concentration of target sample induced by the catalyzed reaction, they
usually require the usage of certain enzyme [31]; while affinity sensors detect
the occurrence of specific biomolecular interactions, such as antigen-antibody
binding or DNA-DNA hybridization [32] .
Between the two, catalytic biosensors have dominated the biosensor market
for decades. For example, one of the most successfully commercialized
biosensors is the biocatalytic electrochemical glucose sensor [33, 34], which
has benefited millions of diabetic patients. On the other hand, affinity sensors
are still largely limited to scientific publications, despite a few commercial
products. In general, there are several challenges hindering the development
of biosensors, most of which are direct against affinity sensors.
Firstly, the detection with affinity biosensor is a two-step process: (1)
immobilization of bioreceptor onto a solid surface and (2) detecting the
3

corresponding change in the surface properties [35]. The stability and activity
of immobilized bioreceptor are therefore of vital importance in determining the
overall performance of the biosensor. For the moment, despite that various
approaches have been studied by different research groups aiming at
improving the stability and uniformity of surface coating [36-40], immobilizing
the bioreceptor onto selected sites while still retaining its activity remains as
one of the top challenges facing the research of affinity sensors.
Secondly, if a biosensor is to be employed for real-time diagnosis with
complex reagents like blood or serum, the surface of the sensor must be
durable and selective enough for the target analyte. Good selectivity (also
known as specificity) [41] enables the detected signal change is caused by
specific interactions instead of nonspecific ones. Selectivity is crucial in reality
where target amount can sometimes be very limited and much less than
interferences [42, 43]. Obtaining adequate selectivity in complex samples such
as blood serum or saliva is another major challenge that has to be overcome
before any practical use of biosensors.
Thirdly, limit of detection is another challenging issue. Although many
publications (biosensors) claim to be able to detect infectious diseases at very
low levels [44-46], most of them are determined in the absence of non-target
interferences. Since it is rare for such clean samples to be realistic in practical
applications, reported limits of detection might be misleading in determining a
biosensor’s real-world performance [35]. In real world detection, biosensors
should be challenged with mixed target/nontarget analytes to verify its feasibility.
Besides, other issues like usability, robustness and financial cost [47] are all
possible limiting factors deterring the practical/commercial application of affinity
biosensors.
In this work, we will design, develop and validate a novel affinity biosensor
which possesses high potential of becoming a feasible point-of-care diagnosis
platform.
4

1.3 Dissertation Outline
This dissertation is organized as follows.
Chapter 2 introduces and compares various types of biosensors based on
different sensing mechanisms. Basic concepts and principles regarding affinitybased biosensing are also mentioned.
Chapter

3

introduces

the

theory

of

electrochemical

impedance

spectroscopy and direct capacitive sensing.
Chapter 4 introduces the basics of AC electrokinetics, including the
importance of inducing ACEK to affinity biosensing and the three phenomena
of ACEK.
Chapter 5 first describes the concept of incorporating capacitive sensing
and ACEK. Afterwards, the whole sensor development process is introduced,
including the design and setup of sensing devices, the development of assay
methods and the characterization of the capacitive affinity sensor.
Chapter 6 presents the detection results of various types of samples,
including antibodies, virus and small molecules. Detailed and in-depth assay
development and optimization are also discussed in this chapter.
Finally, the dissertation works are summarized and future works are
proposed in Chapter 7.
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Chapter 2. Literature review of
biosensors
In recent years, biosensors have attracted numerous research effort
because of their potential to achieve rapid, inexpensive, and portable on-site
diagnosis [48-51]. Yet the design of a feasible biosensor is not an easy task. It
requires deep understanding of multidisciplinary topics including biology,
material science, chemistry and electrical engineering [52]. This chapter
introduces and compares various biosensors such as optical, electrochemical,
piezoelectric and magnetic biosensors. In addition, basic concepts and
principles of affinity-based biosensing are also mentioned.

2.1 Various types of biosensors
A biosensor is composed of two basic elements: a bioreceptor which
enables specific biomolecular interaction and a transducer which converts the
biointeraction into a measureable signal, such as a change in color. Based on
different types of transducers being involved, biosensors can be classified as
optical biosensor (e.g. fluorescence, surface plasmon resonance (SPR) and
chemiluminescence),

electrochemical

biosensor

(amperometry

or

potentiometry, cyclic voltammetry and impedance spectroscopy), piezoelectric
biosensor, magnetic biosensor (e.g. giant magnetoresistive sensing) and etc.
This section provides a brief overview of various biosensors aforementioned.
2.1.1 Optical Biosensors
Optical biosensors have been long studied, and some of them have already
been adopted by the market [53, 54]. As the name implies, optical biosensors
transform the biomolecular interaction into an optical signal, such as a change
in light intensity. This section introduces several types of common optical
6

biosensors.
2.1.1.1 Fluorescent biosensors

Fluorescence means the emission of visible light from any substance when
it absorbs an excitation light of certain wavelength [55]. In fluorescent
immunoassay [56], the detection of target biomolecule is done by using a
“sandwich assay” [57]. Firstly the primary antibody is immobilized onto the
sensor surface, then the secondary antibody which is labelled with fluorophores
will be introduced to bind to the primary antibody. After washing away the
unbound secondary antibodies, the surface will be excited with a light of certain
wavelength so that fluorescence will be emitted and detected. Fluorescence
biosensor can realize quantitative determination since the fluorescence signal
is directly related to the concentration of bound antibodies. Figure 2.1 [58]
demonstrates a fluorescence biosensor developed by some former members
in our group, which successfully detected the binding of bovine serum antibody
to pathogen specific antigen.

Figure 2.1 Fluorescence biosensor developed by previous members of our
group (a) Experimental setup. (b) Fluorescence images of immunoassay.

7

Fluorescent immunoassay is one of the most widespread approaches in
the field of optical biosensor because of its high sensitivity and selectivity.
However, it requires multiple steps for antibody incubation and washing, making
it too time-consuming, complicated and somewhat unreliable to be used for
rapid point of care diagnosis.
2.1.1.2 Surface Plasmon Resonance (SPR) biosensors

SPR technique is an optical method which measures the refractive index
of very thin layers of material adsorbed on a metal film [59]. To capitalize on
that, SPR biosensor measures the change of refractive index at the fluid/solid
interface before and after biointeraction, thus realizing the detection. SPR is
very sensitive to binding since even a tiny increase in mass would lead to a
proportional change in the refractive index at the fluid/solid interface. In this way,
it could monitor the biomolecular interaction information on the substrate.
Figure 2.2 [50] demonstrates the principle of a typical experimental
configuration for SPR biosensor. A thin gold-film on a glass slide is the
transducer, which is optically coupled to a glass prism for the measurement of
refractive index. When biointeraction occurs, the refractive index will change
accordingly.

Figure 2.2 Schematic view of SPR immunoassay.
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The major advantage of SPR biosensors includes its high sensitivity and the
ability to realize real-time detection without any label. However, albeit to the
benefits, SPR biosensor often requires sophisticated optical instrumentation
and highly trained personnel to operate, making it a costly and complicated
method.
2.1.1.3 Chemiluminescence (CL) biosensors

Chemiluminescence is another extensively used optical detection scheme
in immunoassays [60]. CL is the light produced by a chemical reaction. CL
biosensor detects the appearance and/or concentration of samples based on
the intensity of emitted luminescence. As schematically shown in Figure 2.3
[50], samples A and B react with luminol (an intermediate), meanwhile the
emitted light can be detected.

Figure 2.3 Schematic view of CL detection.
CL detection features a very low detection limit [61-63] and wide dynamic.
In addition, compared with other optical methods, it does not require an
excitation light instrumentation, which brings down the cost while eliminates the
background interference. Nevertheless, as it still has a labelling step, CL
detection is sometimes too complicated. Besides, the results could be affected
by environmental factors such as temperature.
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2.1.2 Electrochemical biosensors
Electrochemical biosensors have always been an important part in the field
of biosensing [64-69] . Most electrochemical biosensors feature high sensitivity,
low cost, low power requirement and seamless integration with standard
microfabrication process. Over the past decades, a large amount of
publications and demonstrations of innovative detection schemes have been
presented [70-73].
Electrochemical biosensors work through the detection of an electric signal
resulting from specific biomolecular interactions. Based on the signal
generation principles, electrochemical biosensors are mainly categorized into
three types: amperometric, potentiometric and impedimetric biosensor. This
section provides an overview of these three methods respectively.
2.1.2.1 Amperometric biosensors

Amperometric sensing [49] is one of the most popular approaches among
various electrochemical sensing methods. It is realized through the
measurement of a current at a fixed (potentiostatic technique) or variable
(voltammetric technique) potential [51]. Typical amperometric sensing involves
a three-electrode system, as demonstrated in Figure 2.4 [51], which contains a
working electrode, a counter electrode and a reference electrode. Current is
generated at the working electrode by a redox reaction on the electrode surface.
Redox reaction releases electron so that a current would be generated between
the working electrode and counter electrode, which is proportional to the
amount of the analyte. As the signal is relatively small, enzyme-labeled
antibodies are often used for signal amplification purpose.
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Figure 2.4 Schematic view of a common three electrode system (left) and
actual device (right).
As a simple and straightforward sensing method, technology about
amperometry has matured comparatively in recent years. In fact, many
commercially available point-of-care biosensing systems are based on
amperometric detection [74-76]. Among them, electrochemical glucose
biosensor based on amperometric sensing is regarded as one of the most
successfully commercialized amperometric sensors.
2.1.2.2 Potentiometric biosensors

Potentiometric sensing detects the change on the surface charge or
potential charge upon the occurrence of biointeraction at the interface of the
sensor [48]. Analytes in aqueous solution possess a net charge polarity, which
is related with the isoelectric points [77] of bioparticles and the ionic composition
of the sample reagent. The formation of probe-analyte complex will change the
net charge density compared with that of probe alone, which can be measured
by a potentiometer. A reference electrode in the same solution is set at a
constant potential as a reference.

Aside from the change of net charge, the potentiometric signal can also be
generated by changes in the pH or redox state. Broadly speaking, there are
ion-selective electrodes (ISE) [78], field effect transistor (FET) [79, 80] , and
light addressable potentiometric sensors [81]. As an example, Figure 2.5 [49]
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demonstrates a FET potentiometric biosensor for the detection of human serum
albumin (HAS) antibodies.

Figure 2.5 An extended-gate FET biosensor for HAS antibody detection.
2.1.2.3 Impedimetric biosensors

Impedimetric biosensors are based on impedance measurements of the
biosensing system [35, 82]. It can characterize the electrical properties of the
system without destroying it. An alternating current (AC) signal is applied
between a pair of working electrodes, in this way the electrolysis of the
electrodes [83] can be eliminated, providing a more accurate and authentic
readout. In a microfluidic immunoassay, the variation of the impedance caused
by the biomolecular interaction can be measured by an impedance analyzer
[84]. One of the greatest advantages of impedimetric sensor is that label-free
detection could be easily realized.
Recently, the research on impedimetric biosensors is directed in several
directions [85], such as improving immobilization methods of receptors [86-89],
exploring nanostructured electrode to amplify detection signal [39], and
investigating equivalent circuit or data processing algorithm to effectively
correlate analyte concentration with impedance change [90, 91] .
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To sum up, compared with optical biosensor which normally requires
specific and complicated equipment, most electrochemical biosensors can be
readily fabricated from various conducting substrates using standard chip
manufacturing methodologies. The relative low cost of electrochemical
biosensor is one of the main reason that it is attracting extensive attention from
both academia and industry.
2.1.3 Piezoelectric biosensors
When electric field is applied on the quartz crystal, mechanical deformation
will be produced. On the contrary, when mechanical stress is applied, electric
field will be generated [50]. This phenomenon is known as piezoelectric effect
and the material with this characteristic is called a piezoelectric material [92].
The basic equations describing the relationship between the resonant
frequency of an oscillating piezoelectric crystal and the mass deposited on the
crystal surface is known as the Sauerbrey equation [93]:
∆F = −2.3 ∗ 106 𝑓 2

∆𝑚
𝐴

(2.1),

where F is the frequency change in oscillating crystal in Hz, f is the frequency
of piezoelectric quartz crystal, m is the mass of deposited analyte, and A is
the area of electrode surface. According to this equation, if biointeractions take
place at the surface, the resonance frequency of the piezoelectric crystal would
change based on the concentration of the analyte, thus quantitative analysis
can be achieved. Figure 2.6 [94] demonstrated the schematic of piezoelectric
biosensing system.
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Figure 2.6 Experimental apparatus of a typical piezoelectric biosensor.
The most widely applied piezoelectric biosensor is quartz crystal
microbalance (QCM), which is also known as “micro weighing instrument” [50,
95]. It works based on the piezoelectric effect to measure the mass of change
on the sensor surface without the usage of label. For a classic QCM, a thin
quartz crystal is placed between two electrodes, which serve to generate an AC
electric field across the crystal. Under the generated field, crystal will vibrate at
its resonance frequency (usually around 10-50 MHz). The vibrational
displacement of the crystal changes with mass loading, thus enabling the
measurement of the change in the resonant frequency of the crystal. QCM is
highly sensitive to mass. For instance, Su et.al [96] reported a QCM sensor for
the detection of E.Coli O157: H7 with a detection limit of 103 CFU/mL.
Compared with optical biosensors, piezoelectric biosensor does not require
a labelling step, which is its biggest advantage. In addition, it features high
sensitivity, real-time readout, and low cost. Nevertheless, the greatest limitation
facing piezoelectric biosensor is its accuracy and repeatability, since it is
extremely hard to achieve a uniform surface coating with piezoelectric materials.
2.1.4 Magnetic biosensors
Magnetic biosensing introduces magnetic beads as label particles (see
Figure 2.7 [97]). After the occurrence of biointeractions, the formation of the
biocomplex is measured by detecting the appearance of the magnetic particles,
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which can be performed in several ways. A simple method to detect magnetic
particles is to measure optically the fraction of the surface that has been
covered, yet it does not exploit the magnetic features of the particle. To
capitalize on that, a more general way is to detect the changes in the magnetic
field caused by the presence of the magnetic particles, which is performed by
using giant magnetoresistance sensor (GMRS) [98]. When magnetic particle
gets close to a GMRS, the resistance of the magnetoresistor will decrease
because the magnetic field is influenced by the magnetic particles. Figure 2.8
[99] demonstrates a GMRS detecting the binding of streptavidin to biotin. It
should be noted that magnetic particles need to be aligned, otherwise the
magnetic field will cancel each other.

Figure 2.7 Schematic of immunocomplex labelling with a magnetic particle.

Figure 2.8 A GMRS for the detection of the recognition between streptavidin
and biotin.
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In addition, magnetic biosensors have been demonstrated in the detection
of many other biological samples such as the antigen of Y.pestis [100],
polycyclic aromatic hydrocarbons [101] and colorectal circulating cancer cells
[102] with very low limit of detection. It is regarded as a good competitor for
point-of-care applications but requires further developments with respect to
fluidic delivery and usage with clinical samples. Another drawback of magnetic
biosensors is the requirement of label, which further complicates the procedure.

2.2 Comparison of different biosensing techniques
Based on different sensing mechanisms aforementioned, here we listed the
advantages and disadvantages regarding each type of biosensors in Table 2.1.
Table 2.1 Advantages and disadvantages of different types of biosensors.
Sensor Types

Advantages

Disadvantages

Fluorescence

High sensitivity; good
stability; real-time
detection

Complicated steps; time
consuming; costly equipment

SPR

High sensitivity; noninvasive; label-free; realtime detection

sophisticated optical
instrumentation ;highly
trained personnel required

CL

Low detection limit; wide
dynamic; relative low cost

Complex procedure; label
required; can be affected by
environmental factors.

Amperometric

Simple, straightforward;
easy to integrate;

Low sensitivity; poor stability.

Potentiometric

High specificity; label-free

Low sensitivity; toocomplicated.

Impedimetric

Label-free; low cost; easy to
perform

Lack of specificity

Piezoelectric biosensors

Ultra high sensitivity
(pictogram level); label-free

Poor repeatability; poor
stability

Magnetic biosensors

Low detection limit; high
sensitivity

Label required; hard to be
integrated into a platform.

Optical
biosensors

Electrochemical
biosensors

Compared with other sensing techniques, microelectrode impedimetric
biosensing is rather advantageous due to its simplicity in operation and its low
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cost in fabrication. Moreover, the ability to achieve in-situ detection without the
requirement of labelling makes it even more promising towards the building of
a reliable and feasible biosensor for real world diagnosis.

2.3 Affinity-based biosensing
Affinity biosensors detect biological particles based on specific binding
between analyte and probe molecules, as schematically shown in Figure 2.9.
Probe molecules, also known as bioreceptors, are first immobilized onto a solid
surface prior to adding the analyte sample solution. The analytes of interest are
then introduced and form probe-analyte complexes at the surface [103]. A
transducer is involved to transform the biological interaction into a measureable
signal (either optical, electrical or etc.), which can thus be measured by the
appropriate instrument.

: Probe molecule

: Sample analyte

: Interfering molecules

Figure 2.9 Basic components of affinity biosensor.

2.3.1 Important metrics
Several important metrics used to judge the performance of a biosensor
are sensitivity, specificity, reproducibility, reliability and etc. Sensitivity may refer
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to two different concepts: one is the lowest detectable analyte concentration,
which is more commonly known as the limit of detection (LOD) [104]; the other
is how detection signal changes when the analyte concentration changes, i.e.
the slope of the calibration curve [105]. In this work, sensitivity refers to the
latter definition and it’s differentiated with LOD. Specificity, also known as
selectivity, means the ability of the sensor to detect the analyte of interest while
other interfering molecules are present, which is often the case of real biological
samples. In addition, reproducibility represents the sensor’s ability to reproduce
the same study by either the same person or a different researcher
independently. Reliability, as a whole, depends on both the sensor’s specificity
and reproducibility [65]. All of these aforementioned metrics would together
determine the feasibility of a biosensor to be applied for real world diagnosis.
2.3.2 Detection: label vs label-free; end-point vs real-time [103]
Biosensors are able to provide a quantitative detection of analytes of
interest, as the measurable signal is directly related to the concentration of the
analyte. Depending on whether a label molecule is needed to generate a
readable signal, analyte detection can be classified as labeled or label-free
detection. Label molecules are molecules with unique properties such as
fluorescent particles [106, 107], chemiluminescent particles [108, 109] or redox
markers [70, 110]. Figure 2.10 shows an example of a horseradish peroxidase
(HRP) labeled antibody, which is commonly used in immunoassay to as a signal
amplifier [111, 112]. Prior to labeled detection, label molecules are attached to
the analyte of interest, thus the detection of sample analyte can be achieved
through the detection of label molecules. The usage of labeled detection usually
enables much higher sensitivity, as the signal is enhanced by the unique
properties of the labels [48].
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Figure 2.10 An HRP labeled antibody conjugate.
(Source: http://www.rockland-inc.com/custom-antibody-conjugation.aspx)

Compared with labeled detection, label-free detection, which enables direct
detection of analyte of interest, is attracting more attention in recent years [35,
113, 114]. Labeling can sometimes be problematic. For example, it is difficult to
label irregular or tiny molecules. Besides, labeling complicates the procedure
and brings more uncertainty to the detection [115].
Another way of classifying detection methods is based on the time point
where actual detection occurs. End-point detection occurs after the
biointeraction is stopped, it is a single point measurement of the probe-analyte
complex. As a result, it causes more inaccuracy and only limited reaction
information can be obtained. Real-time detection [116-118], on the other hand,
measures the reaction continuously while the biointeraction is taking place, thus
allowing instantaneous and more precise information.
As we could tell, a label-free and real-time detection system [119, 120]
would be more favorable towards the development of biosensors for practical
applications.
2.3.3 Affinity biosensors: prospective
As mentioned in the Chapter 1.2, the majority of affinity biosensors are still
under the level of academic researches either due to the lack of reliability or the
excessive costs. However, compared with catalytic biosensors, affinity
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biosensors are more versatile and flexible in terms of diagnosis applications.
Catalytic biosensors require the usage of catalyst to trigger certain chemical
reaction, which limits their application field and complicates their readout. On
the other hand, affinity biosensors can detect any biointeractions happened at
the sensor surface through various methodologies, thus enables a much
broader application range.
Despite current challenges, current researches regarding affinity biosensors
have demonstrated their potential to become feasible and effective tools for real
world disease diagnosis in the near future.
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Chapter 3. Basics of capacitive
sensing
3.1 Electrochemical Impedance Spectroscopy (EIS)
Among various affinity-based sensing methods, impedimetric sensing is
promising due to its reasonable cost, ease of operation and the ability to realize
label-free and real-time detection. In this chapter, we start with the introduction
of Electrochemical Impedance Spectroscopy (EIS), which stands as the
fundamental of impedimetric sensing techniques.
3.1.1 EIS introduction
Electrochemical impedance spectrum [121-123] analysis is a wellestablished method for characterizing an electrolytic cell. Usually a small signal
perturbation is applied to the electrode across a wide frequency range, the
corresponding magnitude and phase responses are measured and plotted as
the impedance spectrum [103]. In EIS, a network of electronic components can
be developed to represent an electrochemical cell. A change in the EIS spectra
can be correlated with a change in the (di) electric properties near the
electrode/electrolyte interface due to biomolecular interactions. The ability of
realizing label-free detection with relatively easy configuration has made EIS a
popular biosensing method for decades [124].
3.1.2 Circuit network of electrode-fluid system
The impedance of an electrode immersed in liquid can be approximated as
a network of capacitive and resistive components, as conceptually shown in
Figure 3.1. It consists of fluid resistance (Rf) and capacitance (Cf), which
represents the resistance and capacitance from the bulk fluid; and charge
transfer resistance (Rct) and interfacial capacitance (Cint), which origins from the
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electrode/fluid interface. EDL refers to the electric double layer [125, 126],
which usually forms at the electrode/fluid interface. EDL will be discussed in
detail in the next section. The charge transfer resistance [127] is attributed to
the interactions of ions in the solution with the electrons in the electrodes which
produce a current.

Figure 3.1 Circuit model of the electrode-fluid system.
There are two types of electrochemical reactions: Faradaic reaction and
non-Faradaic reaction. If charge transfer across the interface is cause by the
flow of a DC current, it is regarded as a Faradaic reaction. For Faradaic reaction,
charge transfer resistance is the dominating factor of the impedance response.
On the other hand, if no DC current flows across the interface and the charges
are associated with the movement of ions, the reorientation of dipoles [126] and
etc., it is regarded as a non-Faradaic reaction. This work focuses on affinity
sensing based on non-Faradaic reactions, in such cases, interfacial
capacitance will dominate the impedance response of the system [103].
Figure 3.2 shows an impedance spectrum of an electrode-fluid system,
which is also known as the Bode plot [128]. Bode plot provides frequency
related information, which can be related to the equivalent circuit model of the
system: at low frequency range (usually <100 Hz), Rct dominates the
impedance, therefore it favors the sensors base on Faradaic reaction; while at
high frequency range (usually >1 MHz), the impedance will be dominated by Rf
and Cf, which have almost zero impact to interface impedance. For affinitybased biosensing, most biointeractions happen at the interface, therefore such
high frequency range becomes inappropriate. Only at intermediate frequency
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range (from several kHz upto several hundred kHz) will the impedance be
dominated by interfacial capacitance, which serves as the proper frequency
range for this work.

Figure 3.2 Impedance spectrum of an electrode-fluid system.
Another popular method for impedance presentation is Nyquist plot, where
the real part of the impedance is plotted on the X-axis and the imaginary part is
plotted on the Y-axis [129]. Figure 3.3 shows a Nyquist plot obtained using the
proposed circuit model. Nyquist plot is mostly applied to sensors based on
Faradaic reaction, as Rf and Rct can be easily determined from it [130]. As
shown in Figure 3.3, the diameters of the two semicircles would be the value of
Rf (the smaller one on the left) and Rct (the larger one the right), respectively.
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Figure 3.3 Nyquist plot of an electrode-fluid system.

3.2 Direct capacitive biosensing
Albeit its usefulness, regular EIS requires complex data analysis to extract
the relevant biological information. In recent years, direct capacitive biosensing
has become an active embranchment of impedimetric sensing [131-133], as its
ability to convert a signal of biomolecular interaction straight to a change in
capacitance.
3.2.1 Electric double layer
When a solid material is immersed into an electrolytic solution, the solid
surface will acquire surface charges. To maintain charge neutrality, a thin layer
of counter ions is formed at the solid/liquid interface to neutralize the surface
charges at the solid surface, which is commonly known as the electric double
layer (EDL), as schematically shown in Figure 3.4 [126]. Electrically, EDL can
be modeled as a capacitor. The layers of counter ions and surface charges are
equivalent to the two plates in a capacitor, and the plate separation distance is
the EDL thickness, which is characterized by Debye length (κ-1) [134]. Debye
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length defines the distance where potential decays exponentially from ∅0 (y=0)
to

∅0⁄
-1
𝑒 (y=κ ), which is approximately the range that the applied potential can

change the charge distribution in the bulk solution. This represents the range
that the changes of charge distribution, due to biointeractions, can lead to the
changes in interfacial capacitance [103].

Figure 3.4 Schematic diagram of EDL together with the variation in potential
with distance y from the surface.

The value of Debye length is given by Eqn (3.1) [126]:
𝜀𝑘 𝑇

κ−1 = √2𝑧 2 𝑞𝐵2 𝑛 ,
0

(3.1)

where 𝜀 is the permittivity of the electrolyte, 𝑘𝐵 is the Boltzmann constant,
𝑇 is the temperature, 𝑧 is the valence, 𝑞 is the charge on a single electron
and 𝑛0 is the number density of charge. Debye length is inversely proportional
to the electrical conductivity of the fluid. For most biological reagents, it is a few
nms thick [126, 134].
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3.2.2 Interfacial capacitance
Capacitive biosensors exploit the change in thickness or dielectric
properties of the dielectric layer at the electrolyte–dielectric interface, which will
lead to a change in the interfacial capacitance of the device upon the
occurrence of biointeractions.
The interfacial capacitor consists of a series connection of equivalent
capacitors caused by EDL and biomolecule deposition. When biomolecules are
adsorbed onto the electrode surface, the interfacial capacitance (Cint) will
change due to the change in the thickness and surface area of Cint, which can
then be used to indicate the deposition of biomolecules or particles on the
electrode as well as to be correlated with the biomolecule or particle
concentration in the fluid. The whole process is schematically shown in Figure
3.5 (using antigen-antibody binding as an example).

Figure 3.5 Changes at the electrode surface due to the binding of specific
antibody to immobilized antigen.
As schematically shown in Figure 3.5, at first the interfacial capacitance of
bare electrode is given as:
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Cint,0 = 𝜀𝑠 Aint ⁄λ𝑑 ,

(3.2)

where 𝜀𝑠 is the permittivity of the solution, Aint is the surface area of the
interfacial capacitor of the electrode, and λ𝑑 is the thickness of the double layer.
Then, after the electrode surface is deposited with antigens, the capacitance
changes to:
Cint,ag = Aa ⁄((1⁄𝜀𝑝 ) 𝑑𝑎𝑔 + (1⁄𝜀𝑠 )λ𝑑 ) ,

(3.3)

where 𝜀𝑝 is the permittivity of the antigen probes. The relative permittivity of
probe is around 2-3 [135] , while that for water solution is around 80. Aa is the
surface area after antigen deposition, and 𝑑𝑎𝑔 is the antigen thickness. At last,
after the antibody binding reaction, the dielectric layer becomes the sum of the
EDL (λd), the antigen probe (𝑑𝑎𝑔 ), and the bounded antibodies (𝑑𝑎𝑏 ). As a result,
the interfacial capacitance changes to:
Cint,ab = Ab ⁄[(1⁄𝜀𝑝 ) (𝑑𝑎𝑔 + 𝑑𝑎𝑏 ) + (1⁄𝜀𝑠 )λ𝑑 ] ,

(3.4)

where Ab is the surface area of the interfacial capacitor after binding, 𝑑𝑎𝑏 is
the antibody thickness. Subtracting Cint,ag by Cint,ab , we could get the relative
change of interfacial capacitance caused by antibody binding (assuming
that Aa ≈ Ab ):
∆C/Cint,ag =

Cint,ab −Cint,ag
Cint,ag

𝜀
= −𝑑𝑎𝑏 /[(𝑑𝑎𝑔 + 𝑑𝑎𝑏 ) + ( 𝑝⁄𝜀𝑠 )λ𝑑 ],

(3.5)

Consequently, the surface binding, i.e. the addition of𝑑𝑎𝑏 , can be detected
through ∆C/Cint,ag .
Furthermore, since ∆C/Cint,ag can be directly correlated with the amount
of bounded biomolecules on the electrode surface, capacitive sensing is a
quantitative detection method to a certain extend. In reality, when measuring
the

impedance

of

an

electrode/electrolyte

cell,

there

always

exist

inconsistencies from sensor to sensor, mostly due to the variations in electric
properties of real life samples and the bottom-up nature of surface
functionalization. As a result, the baseline and initial capacitances will have a
range instead of a well-defined value. Using the capacitance change rate, the
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uncertainty in test results can be reduced, since the aforementioned test
variations will largely be factored out.
The aforementioned change of interfacial capacitance can be either
positive or negative, as conceptually shown in Figure 3.6. Antibodies are
deposited onto the surface because of binding. The thickness of the dielectric
layer increases, which could cause a decrease in the interfacial capacitance
(Figure 3.6a). On the other hand, randomly deposited antibodies could cause
an increase in the interfacial capacitor’s surface area due to extra topology
introduced by the antibody, especially when the probe (antigens) are spaced
apart, leading to a higher interfacial capacitance (Figure 3.6b). Both changes
could occur during the binding. Oftentimes, one type of change dominates over
the other, then the detection of binding is possible.

(a)

(b)

Figure 3.6 Two possible topology changes at the solid/fluid interface due to
protein binding reaction. (a) The thickness of the interfacial layer increases
while its surface area decreases, Cint reduces as a result; and (b) when the
increase in the surface area of Cint dominates over the changes in its
thickness, Cint increases. (Ab: antibody; Ag: antigen)
The situation in Figure 3.6a, i.e. a decrease in Cint due to antigen-antibody
binding, is more commonly observed [84]. In a diluted buffer, the EDL is
relatively thick. As EDL envelops the antibodies on the electrodes, fine features
on the scale of EDL thickness (dedl) will be lost, and the Cint change will be
dominated by an increase in its thickness, i.e. Cint reduces. When EDL
thickness is comparable to that of antibody topology, a positive change of Cint
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is possible, especially in a buffer of high ionic strength [136].
In this work, after a great amount of experiments, we found that both an
increase and a decrease in Cint could possibly arise from probe-analyte binding,
depending on the type of sample being tested. Preliminary experiments are
conducted to support the above hypothesis about the interfacial capacitance
change. Buffer of two different ionic strengths, 1 mM and 2 mM phosphate
buffer saline (PBS), are used. The results corroborate that the EDL thickness
(~nm) relative to the characteristic length of deposited macromolecules will
determine whether a decrease or an increase in interfacial capacitance would
result from binding reactions. The detailed results will be discussed in Chapter
6.
3.2.3 Capabilities
In general, capacitive affinity sensing technique has two major functions:
realizing the study of nanoscale surface structure and deposition; and carrying
out the detection of specific surface biomolecular interactions. In this work, the
first function is used for the monitoring surface quality of sensor electrodes,
while the second function is applied to detect specific biomolecular interaction,
such as antigen-antibody binding.
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Chapter 4. Basics of AC
electrokinetics
4.1 The importance of inducing ACEK
Affinity-based biosensors typically rely on passive diffusion of analytes for
binding reaction, which in many cases lead to long detection time and lack of
sensitivity. It could take hours or even days for the amount of bound molecules
to reach a detectable level [137, 138]. To achieve a useful sensitivity within
practical time scales beyond what is dictated by the limitation of molecular
diffusion, active guidance of biomolecules is needed to direct them to sensors.
A number of strategies have been investigated to provide sample concentration
in liquids, such as magnetic particles [139, 140] and optical tweezers [141, 142].
However, those methods are somewhat too complicated for POC testing [5]. In
contrast, electrokinetic in-situ concentration of analytes can be seamlessly
incorporated into capacitive detection to break the diffusion limit.
Alternating current electrokinetics (ACEK), as a particle and fluid
manipulation mechanism, has minimal requirements on the device fabrication
and operation to be incorporated into a detection system, -- only
microelectrodes and their AC signal source need to be added. This chapter
introduces the three fundamental phenomena of ACEK [143]: dielectrophoresis
(DEP), AC electroosmosis (ACEO), and AC electrothermal effect (ACET).
Among them, DEP induces directional particle movement, while ACEO and
ACET manipulate particles through fluid viscosity and gradients in local
conductivity. An order of magnitude estimation of ACEK forces is also provided
and compared with some other natural forces.
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4.2 ACEK for particle and fluid acceleration
AC electrokinetic microfluidics [126] emerged in the 1990s and has been
intensively studied as a means to manipulate particles or macromolecules. It
has been demonstrated by several groups [144-147] that ACEK working with
microelectrodes can induce in situ concentration of particles for improved
detection sensitivity and throughput. Initial studies in our group have
investigated ACEK concentration of biomolecules by both numerical study [148]
and experiments [149, 150]. ACEK effects exploit AC electric field to induce
particle and fluid movement, so that biomolecules can be in-situ concentrated
onto microsensors [151]. When an inhomogeneous AC electric field is applied
to an aqueous solution, both particle movement and fluid microflows can be
induced to transport particles.
4.2.1 Dielectrophoresis (DEP)
The manipulation of particles by DEP is based on the difference between
the particle polarizability and that of the medium solution at a certain frequency
[147]. When a particle is placed in a non-uniform electric field, electric field
density on one side of the particle will be larger than that on the other side,
which would lead to a net force on the particle. This force is called a DEP force.
As shown in Figure 4.1 [152] , DEP force can either be positive (when the
particle is more polarizable than its surroundings) or negative (when medium is
polarizable than the particle). Positive DEP leads the particle to move towards
the high electric filed region, while negative DEP does the opposite.
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(a)

(b)

Figure 4.1 Schematic illustration of DEP force: (a) positive DEP and (b)
negative DEP.

Theoretically, DEP force on a spherical particle can be expressed as follows:
ε∗p −ε∗m

ε∗p −ε∗m

p

p

FDEP = πa3 εm Re [ε∗ +2ε∗ ] ∇|E|2 ≈ πa3 εm Re [ε∗ +2ε∗ ]
where

m

m

|E|2
𝑟

,

(4.1)

 *    j /  is the complex permittivity with ε, σ and ω being

permittivity, electrical conductivity and angular frequency; subscript p and m
denote particle and medium, respectively. Re is the real part of a number, and
ε∗p −ε∗m

[ε∗ +2ε∗ ] is known as Clausius–Mossotti factor (fCM) and is frequency dependent
p

m

with a value between -0.5 and 1. a is the particle radius; E is the electric field
strength, and r is the distance to the center of the electrode gap. fCM determines
the polarity of DEP force: when it is positive, the particle will experience positive
DEP force, moving towards high electric field regions, such as electrode edges;
when it is negative, the particles will experience negative DEP force, being
repelled from electrodes. Positive DEP is employed for particle concentration
in this work.
4.2.2. AC electroosmosis (ACEO) and AC electrothermal (ACET) effect
Based on Eqn (4.1), the magnitude of DEP force depends largely on the
particle volume. In case of nanoscale biomolecules such as antibodies (small
radius), DEP is effective only with high ∇|𝐸|2 , i.e. high electric field gradient,
which means that molecules need to be within a very short distance from the
electrodes to experience sufficient DEP attraction, which can be difficult for
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some circumstances. Fortunately, ACEO and ACET could work as a perfect
complementation, inducing fluid movements which will carry molecules towards
the electrode surface even from a long range.
“AC electroosmosis refers to the microfluidic motions generated at
electrode surfaces when AC signals are applied. It relies on the induction and
movement of mobile charges in the double layer at electrode surfaces and
typically happens at low frequencies when the interfacial impedance
dominates.[143]” The schematic of ACEO flow is shown in Figure 4.2. Moreover,
ACEO typically dominates at low ionic strength. The ﬂow velocity of ACEO has
been observed to decrease signiﬁcantly with increasing conductivity and
eventually drop to zero above 0.085 S/m [153]. For biological applications, the
ionic strength of suspending medium must maintain a certain level so that
biomolecules can stay alive. In this study, phosphate buffered saline (PBS)
containing 15 mM Na+ is used as the medium, with a conductivity of 0.18 S/m,
thus ACEO flow will be negligible.

Figure 4.2 Schematic illustration of ACEO flow.

To actuate fluid at such high conductivities, a feasible option is to use AC
electrothermal effect. ACET has been demonstrated as a promising technique
to manipulate conductive fluids [154-157]. The AC electrothermal effect results
from the interactions of AC electric fields and temperature gradients in the fluid.
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Therefore it favors higher fluid conductivity, since higher temperature gradient
could be generated, leading to stronger ACET flows.
ACET effect could exert volume force on fluid to generate microflows as:
[153, 158]
< 𝐹𝐸𝑇 >= −𝑀(𝜔, 𝑡) (

4
𝜀𝑚 𝜎𝑚 𝑉𝑅𝑀𝑆

2𝑘𝜋3 𝑟 3 𝑇

) ≈ 0.011

𝜀𝑚 𝜎𝑚
𝑘

𝜋𝑟𝐸 4 ,

(4.2)

where 𝑀 is a dimensionless factor which predicts the variation of force with
frequency: for frequencies lower than 1 MHz, i.e.

𝜔𝜀𝑚
⁄𝛿 ≪ 1, 𝑀 = +6.6,
𝑚

where 𝜔 is angular frequency. 𝜀𝑚 and 𝜎𝑚 are the permittivity and conductivity
of the fluid, respectively. 𝑉𝑅𝑀𝑆 is the RMS (root mean square) value of the
applied voltage. 𝑘 is the fluid thermal conductivity; r is the distance to the
center of the electrode gap and T is the temperature in Kelvin.
The schematic of ACET flow is shown in Figure 4.3 [159]. At the frequency
range of this work, ACET flow can be regarded as frequency-independent, and
scales with the electric conductivity of fluid. With planar electrodes, ACET effect
will induce vortices above each electrode, and the microflows will convect the
embedded particles towards the electrode surface [160]. Because fluidic forces
have no dependence on particle size (from Eqn (4.2)), ACET microflows will be
well suited for transporting biomolecules to the electrodes. Furthermore,
previous work by our group member Liu [58] have shown that ACET effect is
playing an important role in increasing detection sensitivity.

Figure 4.3 Schematic illustration of ACET flow.
Combining DEP and ACET effect, nanoscale particles are collected over a
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large range to the electrodes, so as to realize accelerated and sensitive
detection of biomolecular binding reaction.
4.2.3 Order of magnitude comparison: ACEK forces vs. natural forces
For the purpose of showing the effectiveness of ACEK in flow acceleration
and particle concentration, this section compares the relative magnitudes of
different forces (i.e. ACEK forces and natural forces) and their induced flow
velocities.
First, an order of magnitude estimation of DEP and ACET forces is provided
using Eqns (4.1) and (4.2), with parameters assumed to be close to the
application purpose of this work. Table 4.1 lists the parameters involved in
calculation.
Table 4.1 Parameters involved in ACEK force calculation.










𝐄 = 𝑽⁄𝝅𝒓, r= 0.5 um.
Applied voltage: V= 1 Vrms.
Particle mass and size: molecular weight: 150 kDa, which is equal to 2.5e-22
kg. Particle is assumed as spherical with radius of 10nm (a=10 nm)
𝐑𝐞[𝒇𝑪𝑴 ]=1, f= 100 kHz.
Permittivity of medium: 𝛆𝒎 = 𝜺𝒓 𝜺𝟎 = 80*8.85e-12 F/m.
Electrical conductivity of medium: 𝛔𝒎 = 0.18 S/m
Thermal conductivity of medium: k= 0.6 W/ (m*K).
Temperature: T=300 K.
Viscosity of medium: 𝜼= 1e-4 kg/ (m*s).

According to Eqn (4.1), the time-averaged DEP force is calculated to be:
𝐹𝐷𝐸𝑃 = 𝜋𝑎3 𝜀𝑚 𝑅𝑒[𝑓𝐶𝑀 ]𝛻|E|2 ≈ 4.4 ∗ 10−16 𝑁

(4.3)

Then, according to Stokes’ law [161], DEP velocity is calculated to be:
𝑣𝐷𝐸𝑃 =

𝐹𝐷𝐸𝑃
⁄6𝜋𝜂𝑎 ≈ 20 𝜇𝑚/𝑠

(4.4)

As shown in Eqn (4.1), 𝐹𝐷𝐸𝑃 ∝ |E|2 , so if the applied voltage drops to 100
mVrms, DEP velocity will drop to 0.2 𝜇𝑚/𝑠.
Based on Eqn (4.2), time-averaged volume ACET force on fluid is calculated
to be:
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𝐹𝐸𝑇 = −𝑀(𝜔, 𝑡) (

4
𝜀𝜎𝑉𝑅𝑀𝑆

2𝑘𝜋 3 𝑟 3 𝑇

) ≈ 610

N
𝑚3

(4.5)

Again, applying Stokes’ law gives us an estimation of the fluid velocity [153]:
𝑣𝐴𝐶𝐸𝑇 ≈

4
5∗104 𝜀𝜎𝑉𝑅𝑀𝑆

1

𝑘𝜂𝑟

1 𝜕𝜎

|𝜎 𝜕𝑇 | = 42 𝜇m/s

(4.6)

Since 𝐹𝐴𝐶𝐸𝑇 ∝ |E|4 , ACET velocity will drop to 4.2 nm/s if the voltage drops
to 100 mVrms.
Next, let’s consider the effect of natural forces. Gravity is the main external
influence on a particle suspended in a fluid, which is given as:
𝐹𝑔 = 𝑉(𝜌𝑝 − 𝜌𝑚 )𝑔 ≈ 0.2 𝑚𝑝 𝑔 = 5 ∗ 10−22 𝑁,

(4.7)

where 𝜌𝑝 and 𝜌𝑚 are mass densities of particle and fluid, respectively. 𝑚𝑝 is
the mass of the particle. In practical cases, the factor 0.2 might be even smaller
since many particles have densities close to water [153]. It is clear that 𝐹𝑔 ≪
𝐹𝐷𝐸𝑃 , which means gravitational force is negligible compared to electrical forces.
In addition, the effect of natural convection can also be neglected compared to
electrical forces [158].
Other than the aforementioned forces, diffusion driven by Brownian motion
can also move particles [162]. Diffusion is non-deterministic, which means it
could disrupt the directional movement of particles induced by ACEK. However,
many literatures [144, 146, 159, 160] have shown that randomized diffusion is
not strong enough to affect ACEK acceleration and concentration of sub-micro
particles [158].
To sum up, order of magnitude comparison of different forces proves the
effectiveness of ACEK in flow acceleration and particle concentration, which
opens up the opportunity of developing rapid affinity biosensing techniques.
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Chapter 5. Sensor Development
Having introduced the basic theories of capacitive sensing and AC
electrokinetics movement, this chapter will move on to discuss the advantages
of incorporating the two theories together for affinity biosensing. Furthermore,
we will go into the details of device design and experimental considerations as
we describe the development of the ACEK-based capacitive affinity biosensor.

5.1 Incorporation of direct capacitive sensing and ACEK
For the majority of the state-of-the-art impedimetric affinity biosensors,
there are still some obstacles to be overcome for them to be used for POC
detection. First, many impedimetric tests would require sophisticated and
oftentimes time-consuming data processing to extract binding related
information. Expensive benchtop impedance analyzers are usually needed if
high test frequencies (>1 MHz) are used. Second, most of the reported
impedance assays were conducted with highly processed samples. To be
viable as a POC diagnostic system, sample preparation must be simple enough
to be performed on site. Third, as mentioned in Chapter 4, most of the currentlytested systems still require at least 30 minutes to perform a single incubation
step with abundant molecules or even longer time for more diluted analyte.
While this is an improvement over standard enzyme-linked immunosorbent
assay (ELISA) method [163], an incubation time of half an hour or more may
still be too long under some field testing circumstances. For example, testing
multiple wild animals in field would be much more feasible if a more rapid test
becomes available.
In this work, a novel affinity biosensor is developed by incorporating
ACEK effect seamlessly with the signal interrogation process for in situ
biomolecule enrichment and real-time biointeraction process monitoring
through direct capacitance measurement. Unlike conventional impedimetric
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sensing, which uses a low AC voltage of 5-10 mV before and after the
occurrence of biointeraction, the ACEK-based capacitive sensor reads the
electrode impedance continuously with a fixed AC signal at a specific frequency,
which is predetermined based on the biological reagents and sample types
being tested. Such an AC signal would be able to break the diffusion limit by
inducing ACEK effects to convect/attract biomolecules to the electrode surface,
as shown in Figure 5.1. Meanwhile, the applied signal would stay in the “safe”
range, i.e. minimum electrochemical reactions or other impedimetric artifacts
will be involved as interferences.

Figure 5.1 Breaking the diffusion limit by inducing ACEK.

Furthermore, it should be noted that the same AC signal is used to
measure the capacitance (and its change) between microelectrodes, which
directly indicates the activity and level of biointeractions occurring on the
microelectrodes. So in the ACEK-based capacitive assay, analyte enrichment
and capacitive detection are conducted simultaneously. Incorporation of ACEK
with sensors has been investigated for various types of sensors, such as
microcantilevers [164], fluorescent labeled affinity sensing [58], quartz crystal
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microbalance [165], and most commonly seen, impedimetric sensing [166-168].
For all the aforementioned reports, the ACEK concentration step is separate
from the detection step, which is more complicated to operate than the
capacitive assay developed in this work.
Incorporating direct capacitive sensing with ACEK effect, the ACEK-based
capacitive affinity biosensor can be very effective in enriching biomolecules
concentration over a large range and thus realizing accelerated detection at
real-time.

5.2 Device design
This section covers the details about sensor design and instrument setup,
which includes elaborate information about the electrodes and the
measurement devices.
5.2.1 Preparation of microelectrode sensor
The ACEK-based capacitive affinity biosensor utilizes arrays of coplanar
interdigitated microelectrodes, which are obtained in two ways: 1) By modifying
commercially available electrode chips, i.e. surface acoustic wave (SAW)
resonator chips (PARS 433.92, AVX Corp). 2) By in-house fabricating gold (Au)
coplanar microelectrodes on silicon wafer. Images of original and modified SAW
chips are shown in Figure 5.2a, and the scanning electron micrograph (SEM)
of the interdigitated electrode array in the SAW chip is shown in Figure 5.2b.
Meanwhile, images of in-house fabricated gold electrodes are shown in Figure
5.3 (a) and (b).
The reason we choose such type of electrode design is that similar
interdigitated microelectrodes have been used by both our previous group
members [148] and other groups [169, 170] to study ACEK effects, and it is
proved to be very effective at generating DEP effect for particle enrichment as
well as ACET effect for fluid streaming.
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(a)

(b)

Figure 5.2 (a) Commercially available electrode chips, i.e. surface acoustic
wave (SAW) resonator chips (PARS 433.92, AVX Corp). The left one is
modified for immunosensing. (b) A scanning electron micrograph of the
microelectrode array in the SAW chip.

(a)

(b)

Figure 5.3 (a) In-house fabricated gold microelectrodes on silicon wafer with a
silicone chamber on top of it; (b) SEM image of the interdigitated array inside.

The preparation of sensors involves chip modification (if needed) and
electrode cleaning. Let’s first focus on the preparation of SAW electrode chips
The first task is to remove the metal cover of the device to expose the
working electrode array for use. This is done by using an X-Acto knife to first
pierce the top cover near the edge of the chip. After piercing, the next step is to
pry up on the lid to break the edge loose, then cover will be able to be sliced
down. The metal casing around the electrode chip is about 4mm (L) x 2.5mm
(W) x 1mm (H) = 10 µL, serving as a microchamber for sample solutions. The
interdigitated electrodes are made of aluminum deposited on quartz substrate.
Each microelectrode is 1.4 μm wide, 170 μm long, 200 nm thick, and separated
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by a 1.1 μm gap from one another, as shown in Figure 5.2b. The interdigitated
electrodes are electrically connected to two contact pads on the chip bottom,
which will be connected to an impedance analyzer for measurement.
Next, the SAW electrode chips are cleaned with the following procedure:
1. Soak the chips in acetone for 20 minutes.
2. Rinse the chips with isopropyl alcohol (IPA) for 30 seconds.
3. Rinse the chips with purified water for another 30 seconds.
4. Blow-dry the devices with clean air for 10 seconds to remove excess
liquid. Use lab air to blow dry chips.
5. Put the chips into UV Ozone cleaner (BioForce®) for 15 minutes.
The modified SAW resonator will be denoted as SAW electrodes in later
sections.
For gold electrodes on silicon wafer, the fabrication process is described
briefly as follows: 50 nm of gold is deposited on top of silicon substrate which
has 100 nm of SiO2 as insulating layer and 10 nm of chromium (Cr) as adhesive
layer. The fabricated microelectrode arrays have interdigitated configuration
with two different dimensions, symmetric electrodes with a characteristic length
of 2μm (with widths of 2μm separated by 2μm gaps), denoted as 2μm gold
electrodes, and asymmetric electrodes with a characteristic length of 5μm (with
widths of 5μm and 25μm separated by 5μm and 25μm gaps), denoted as 5μm
gold electrodes. The size of the contact pad of each chip is 3 mm* 4mm. After
fabrication, the whole wafer will be diced and each gold chip will be taken down
as an individual sensor, as could be seen in Figure 5.4.

Figure 5.4 Individual sensor after dicing (left: without chamber; right: with
chamber).
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The preparation of gold chip electrodes on silicon is easier, as the working
electrodes are already exposed. The cleaning procedure for gold chip
electrodes is described as follows:
1. Sprinkle acetone on top the chip, wipe the surface with a clean nonwoven wiper for several times.
2. Sprinkle isopropyl alcohol on top the chip, wipe the surface with a
clean non-woven wiper for several times.
3. Sprinkle purified water on top the chip, wipe the surface with a clean
non-woven wiper for several times.
4. Blow-dry the devices with clean air for 10 seconds to remove excess
liquid. Use lab air to blow dry chips.
After electrode cleaning, a silicone microchamber (2.5mm in diameter and
0.9mm in depth, JTR24R, GraceTM Bio-labs) is sealed onto the wafer with
electrodes inside for sample loading, as shown in Figure 5.3a and 5.4. The
liquid amount within the chamber is also around 10 µL, similar to that of SAW
electrodes. In addition, the microchamber is sufficiently high, so that electric
fields and ACEK effects can fully develop, as shown by numerical simulation
[148].
The cleaned SAW electrodes/gold electrodes on wafer will then be saved
for surface functionalization, which is going to be discussed in later sections.
5.2.2 Test fixture and instrument setup
In this work, impedance data is acquired using a high precision impedance
analyzer (Agilent® 4294A) with its 16047E test fixture, and the data is recorded
through its LAN port onto a computer using software Data Transfer V3.0
(SEKONIC®), as shown in Figure 5.5.
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4294A

Data acquisition
software

16047E

Figure 5.5 Agilent 4294A with 16047E test fixture connected with a data
acquisition computer.

For SAW electrode chips, in order to connect the sensor electrodes to the
16047E fixture, two connection wires are soldered to pins on the back of each
chip, as shown in Figure 5.6. The soldered chips will then be connected to the
test fixture of the impedance analyzer.

Figure 5.6 Connection of SAW chip to the test fixture.

In terms of making connection of gold electrode chips, a custom build fixture
is designed for the chips to be mounted, as shown in Figure 5.7. Then the
custom build fixture will be connected to the impedance analyzer.

43

Figure 5.7 Connection of gold chip to the test fixture.

5.3 Assay methods
With sensors and measurement instruments being introduced, this section
moves on to the discussion of assay methods step by step, including electrode
surface cleaning, surface functionalization with probes, surface blocking and
analyte detection method.
5.3.1 Electrode surface cleaning
The quality/cleanness of electrode surface plays an essential part in
determining whether a sensor is usable for biomolecular detection or not. Any
residue or interference remained on the surface might lead to a failure in
detection. Different electrode surface qualities (levels of cleanness) may quite
likely be manifested through the interfacial capacitances, due to variations in
the composition of dielectric layer, surface topologies or the ability to acquire
surface charges. In this work, various electrode cleaning methods are
conducted and their effectiveness are manifested through reading the
interfacial capacitance values, demonstrating the capability of capacitive
sensing described in 3.2.3.
Before moving on to further discussion, it is worth mentioning that two types
of surfaces may exist:
1. Fresh surface, which means the surface has not been treated with any
chemicals or biological stuffs. In this case, the major purpose of cleaning
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is to remove any dirt or impurities that might come from fabrication or
environment. Normally a mild wash is enough. SAW electrode has more
concerns to obtain a clean fresh surface since it involves lots of
modifications. For gold electrodes on wafer, the cleaning for fresh
surface is a largely standardized procedure.
2. Used surface, which means the surface has been treated with
chemicals or biological stuffs. In this case, the goal is to recover the
surface to its fresh state.
Surface cleaning in this section refers to the cleaning of fresh surfaces with
the focus on SAW electrodes.
As listed in the explanatory text of Figure 5.8, three different cleaning
methods have been tried to clean SAW electrodes. After each trial, interfacial
capacitances of bare electrodes are measured with an excitation signal of 5
mVrms. 0.1x phosphate-buffered saline (PBS), which refers to 1 mM phosphate
buffer (pH 7.0) containing 15 mM NaCl, is used as measuring buffer for
capacitance measurement. PBS is a buffer commonly used in biological studies,
which is isotonic and non-toxic to bioparticles.
For SAW electrodes, since reactance at 100 kHz represents closely that of
the interfacial capacitor, capacitance values at 100 kHz are adopted as the
indicator of the interface conditions. Strong correlation between the interfacial
capacitance values and the cleaning methods has been found, as shown in
Figure 5.8.
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Figure 5.8 Capacitance values with different washing methods. For each
condition, five chips are measured.
(1): no wash
(2): wash with DI water only
(3): wash with acetone-IPA-DI water
(4): wash with acetone-IPA-DI water-Ozone cleaner
Lowest capacitance values are found when no wash is applied. Capacitance
values gradually increase with the addition of cleaning steps, particularly
noticeable between methods (2) and (3), (3) and (4). This could be explained
by the hypothesis that before cleaning, the electrode surface is covered by a
thin film of dielectrics (possibly from unintended growth or deposition of
contaminants or other materials), while with added/more aggressive cleaning,
the thickness of the film is reduced or the area covered by the film is getting
less. According to C=εS/d (d is the thickness of surface film), with d decreasing,
C would certainly increase. As a result, we choose method (4) for cleaning the
electrodes, as has already been mentioned in 5.2.1.
The cleaning of gold electrode surface mentioned in 5.2.1 is the widely
accepted effective procedure for wafer cleaning, hence it will not be discussed
here.
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5.3.2 Surface functionalization
For affinity-based biosensors, prior to analyte detection, a layer of probe
molecule needs to be immobilized onto the electrode surface to realize
biospecificity. This step is known as surface functionalization. The quality of
surface functionalization is crucial to the successful detection of analyte, as it
determines the number of available binding sties. Generally speaking, there are
two types of surface functionalization methods: passive adsorption and the
usage of linker molecules. In this work, both of these methods are adopted and
their effects are compared.
5.3.2.1 Passive adsorption

Biomolecules can be directly attached to metal surface due to the
hydrophobic and electrostatic interactions between each other [103, 136].
Passive adsorption of probe molecules, also known as direct attachment, is the
simplest way of functionalizing a surface, which involves only the incubation of
electrodes with a solution containing the probe molecules for a certain period
of time (usually several hours to overnight).
For passive adsorption, the major concern is functionalization time.
Incubation time could largely influence the quality of the probe layer. Therefore,
in order to seek the optimal incubation time, a commonly used protein molecule
(bovine IgG whole molecule) labelled with fluorescent dyes (concentration: 100
ng/mL, diluted in 0.1x PBS) are immobilized on 5μm gold electrodes for different
amount of times (6hrs, 12hrs and 24hrs). After washing away any unbound
molecules, the electrodes are observed under a confocal microscope (Nikon®
LV-100D FLUOR Microscope) for functionalization quality check, as shown in
Figure 5.9.
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Figure 5.9 (a)-(e) Microscopic images of incubated electrodes. Left column
shows the actual image, right column shows the light intensity.
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(a) Control- blank electrode

(b) Control- electrode incubated with 0.1xPBS solution

(c) After 6 hours of incubation with IgG

(d) After 12 hours of incubation with IgG

Figure 5.9 continued.
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(e) After 24 hours of incubation with IgG

Figure 5.9 continued.
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For PBS diluted protein molecules, it is clear that six hours incubation
produces a relatively stronger and more uniform surface functionalization. Thus
six hours is adopted as the functionalization time for passive adsorption for PBS
diluted molecules. While for ethanol diluted probe molecules, since it is not able
to process a fluorescent label, we choose the most widely applied
immobilization time in a traditional ELISA test [171], which is overnight (~16 hrs).
Although biomolecules can be immobilized to the electrode surface
through passive adsorption, it has several limitations [103]:
1. Hydrophobic and electrostatic bonds are weak bonds. As a result,
biomolecules can be easily removed from the surface using certain
solvents or detergents.
2. The surface coverage by passive adsorption might be low especially for
biomolecules with different shapes, sizes and orientations [82].
3. It is hard to realize uniform coating by passive adsorption.
5.3.2.2 Usage of linker molecules

Compared to passive adsorption, the usage of linker molecules serves as
a better surface functionalization method, as it is able to form strong covalent
bond between biomolecules and electrode surface. Moreover, linker molecules
tend to form self-assembled monolayers (SAM) on the electrode surface, which
possess well-defined composition, structure and thickness [172-174].
Therefore a uniform coating is more likely to be realized by applying linker
molecules.
Thiols and polysiloxanes have been widely applied as effective linkers for
probe immobilization [175, 176]. Functional thiol groups are commonly used on
gold surfaces because they have thiol compounds (S-H groups) which possess
very strong affinity to gold surfaces [172]. On the other hand, polysiloxanes are
more frequently used on metal oxide surfaces, as they could form SAMs on
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metal oxide surface by silanol (-Si-O-) and siloxane (-Si-O-Si-) [177].
In this work, SAW electrodes are made of aluminum, which is easily
oxidized under its neutral state. As a result, 3-aminopropyltroethoxysilane
(APTES) [178], as one of the most extensively used polysiloxanes, is applied
as the linker molecule for SAW electrodes. While for gold electrodes, functional
thiol groups are applied as the linker molecules. Figure 5.10 shows the
chemical structures of APTES (a) and thioctic acid (b), which is a commonly
used functional thiol linkers [103].

(a)

(b)

Figure 5.10 Different types of linker molecules. (a) APTES and (b) thioctic
acid.
(Source: 3-Aminopropyltriethoxysilane | 919-30-2". Chemicalbook.com. Retrieved 2012-08-01.)

5.3.2.2.1 APTES treatment

As schematically shown in Figure 5.11, on one end, APTES has nonhydrolysable hydroxyl groups which can bond strongly to metal oxides; on the
other end, it has amine groups that can form strong interaction with amino group
in biomolecules [179]. Therefore, biomolecules would form a much more stable
and stronger bond with the electrode surface.
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Figure 5.11 Schematic of APTES treatment of a substrate.

After a fair amount of trial, the procedure for APTES treatment for SAW
electrodes is set as follows:
1. Cleaned SAW electrodes are exposed to 10v/v% APTES in absolute

ethanol for 15 minutes under room temperature.
2. The electrodes are rinsed with 96% ethanol three times, dried with air

gun and then baked at 125°C for 30 min.
3. The electrodes are incubated with 2.5v/v% glutaraldehyde for 1 hour at

room temperature. Glutaraldehyde is used to modify the chemical
reactivity of the formed SAMs [175].
4. The electrodes are washed with DI water for three times.
5. The electrodes are incubated with solution containing probe molecules

(protein in this work) for five hours in a humidor at room temperature.
6. The electrodes are washed with 0.1x PBST, which is 0.1x PBS

containing 0.05 v/v% Tween 20 (Fisher Scientific, Pittsburgh, PA), for
three times to remove any unbound probe molecules

Similar to that of electrode surface cleaning, the effectiveness of APTES
treatment is checked through reading the capacitance values, as shown in
Figure 5.12. As could be seen, APTES-treated chips showed much smaller
capacitance, since most part of the electrode surface is covered by nonhydrolysable hydroxyl groups and amino groups, causing the loss in its
dielectric properties.
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SAW aluminum electrodes

Figure 5.12 Comparison of capacitances between washed bare SAW
electrodes and APTES-treated SAW electrodes. Five chips are measured and
their capacitance values are plotted.

5.3.2.2.2 Thiol mediation

As aforementioned, thiol linker has S-H groups at their terminal ends which
could form strong bond with the gold surface. Meanwhile, the head group of
thiol linker is carboxylate group, which could be further activated for
biomolecule binding.
In this work, the formation of functional thiol groups is described using 3MPA (3-mercatopropionic acid), which is a commonly used thiol linker: (Figure
5.13 gives a schematic of the thiol formation and activation.)
1. Cleaned gold electrodes are modified by immersion of 1mM 3MPA and
50 mM PBS buffer (pH =10) for 17 hours to form a self-assembled
monolayer with carboxylate termination. Alkaline pH is employed to
increase the solubility of 3-MPA in PBS buffer.
2. After 17 hours, the electrodes are cleaned with distilled water.
3. The terminal carboxylate groups are then activated for 1 hour in 75mM
EDC and 15 mM NHS [180] in 50 mM PBS buffer (pH=7.3). After
EDC+NHS activation, ester groups in NHS will be able to form strong
covalent bond with the amino group in biomolecules.
4. The electrodes are then cleaned with 0.1x PBST for three times.
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5. The electrodes are then immersed for two hours into a solution
containing probe molecules and 50 mm PBS at pH 7.3, forming amide
bonds to the protein surface.
6. The electrodes are then cleaned with 0.1x PBST for three times to
remove any unbound probe molecules.

After formation of thiol
SAM.

Activation of SAM with
NHS+EDC.

Figure 5.13 Schematic of thiol SAM formation and activation with NHS+EDC.

Again, the effectiveness of thiol mediation is also checked by reading
their capacitance values, as shown in Figure 5.14. Compared with bare gold
electrodes, thiol-mediated electrodes showed smaller capacitance values,
which proves that the thiol groups are functional.

Gold electrodes

Figure 5.14 Comparison of capacitances between washed bare gold
electrodes and thiol-mediated gold electrodes. Five chips are measured and
their capacitance values are plotted.
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5.3.2.3 Comparison

Here we summarizes and compares the pros and cons of passive adsorption
and the usage of linker molecules, as shown in Table 5.1.

Table 5.1 Comparison between passive adsorption and linkers.
Passive Adsorption

Linker molecules

Simple to operate, easy to be

More complex to operate; harder to be

removed

removed

Weak bond: hydrophobic and
Strong bond: covalent bond between
electrostatic interactions.
molecules and surface. Irreversible.
Can easily be reversed.
Well-defined composition, structure
Low surface coverage, especially for
and thickness. Enables more stable
proteins and antibodies.
and uniform coating.

Effects of different functionalization methods will be compared in Chapter 6 when
related analyte detection results are mentioned.

5.3.3 Surface blocking
After surface functionalization, surface blocking will be performed to cover
any unoccupied space on the electrode surface to minimize non-specific
binding. In this work, blocking buffer used is buffer B, which is PBS-T containing
10 v/v% SuperBlock (PIERCE Biotechnology, Rockford, IL). Different blocking
times and concentrations of blocking reagent (0.1x, 0.2x or 1x) might cause
different impacts towards analyte detection. The impact of blocking will also be
discussed in Chapter 6.
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5.3.4 Analyte detection
After surface functionalization and blocking, the probe-coated electrodes
will be washed with 0.1x PBST to remove any unbound molecules. Then the
electrode chips will be connected to the impedance analyzer and analyte
samples will be introduced to the surface for detection.
When sample analyte is introduced, the interfacial capacitance of the
electrode is continuously measured at a predetermined frequency for a certain
period of time (from 15 seconds to 2 minutes, depending on the binding activity).
ACEK-based capacitive affinity sensing method adopts a dimensionless
quantity – the percentage change in the measured capacitance to indicate
analyte deposition onto the electrode, which is the slope of normalized
capacitance change versus time (%/minute) and found by least square linear
fitting method [181]. Normalized capacitance is calculated as
Norm (Cint, t) = Cint, t/ Cint, 0, where Cint, t and Cint, 0 are the measured
interfacial capacitances at time t and time zero, respectively. Doing so
circumvents the need for a reference sensor, minimizes size difference from
sensor to senor, further simplifying the detection procedure and instrumentation.
5.3.5 Summary
Overall, the basic steps of the capacitive affinity biosensing is summarized
in Figure 5.15.

Figure 5.15 Summary of assay procedure.
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5.4 Sensor Characterization
In the development of the capacitive affinity biosensor, impedance spectra
analysis of the electrode-fluid system is conducted to determine which circuit
elements would predominately account for the biomolecular interaction. As
mentioned in Chapter 3, EIS analysis is a well-known characterization method
for impedimetric based affinity sensor to relate the biomolecular interaction with
corresponding changes in electric signals.
5.4.1 Extracting the values of circuit elements
Upon the occurrence of biomolecular interaction, impedance spectra of the
electrode-fluid system would change accordingly. By fitting the impedance
spectra with the proposed equivalent circuit model, biomolecular interaction
would be corresponded to changes of resistance and/or capacitance values of
the model.
Since SAW electrodes and gold electrodes have different materials and
designs, values of circuit elements would be different between the two types of
sensor.
SAW electrodes are first examined. 0.1x PBS is adopted as measuring
buffer. 10 ng/mL goat anti-bovine IgG antibody (analyte) binding with
immobilized bovine IgG (probe) is used to represent biomolecular interaction.
Before and after the analyte binding step, impedance spectra of the electrodefluid system are recorded at 5 mVrms from 10 kHz to 1 MHz, a range of the
most interest to our detection. The proposed equivalent circuit model is
employed for curve fitting and extracting component values. The measured
impedance spectra together with fitted curves are shown in Figure 5.16, with
extracted circuit parameters given in Table 5.2.

58

Figure 5.16 Comparison of measured impedance spectra and curve fitting
using the four element equivalent circuit model of SAW electrodes.
(Frequency range: 10 kHz-1MHz. Signal applied: 5 mVrms.)
Table 5.2 Equivalent circuit parameters obtained by curve-fitting the
experimental results for SAW electrodes.
Steps
Before binding

Rct(Ω)
750

Cint (nF)
30

Rf(Ω)
1750

Cf (pF)
3

After binding

800

24

1850

3

Of the four circuit elements listed in Table 5.2, Rct and Cint describe the
electrical properties at the electrode-fluid interface, while Rf and Cf describe the
properties of the bulk fluid. Since the enrichment effect by ACEK is the most
pronounced at 100 kHz, it is adopted as the testing frequency in our ACEK
impedance sensing. At 100 kHz, the reactances for Cint and Cf are calculated
to be ~53 Ω (<<Rct) and 530 kΩ (>>Rf), respectively. It can be seen that Cint and
Rf dominate the impedance response for the frequency of interest to this work
(100 kHz). Consequently, the equivalent circuit in the inset of Figure 5.16 can
be simplified to a series connection of Rf-Cint as shown in the inset of Figure
5.17. In Figure 5.17, the impedance responses from the Rf-Cint serial connection
are plotted along with the measured impedance spectra, and good agreements
between them can be seen over the frequency range of 10 kHz-1MHz.
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Figure 5.17 Comparison of measured impedance spectra and curve fitting
using simplified Rf-Cint serial connection for SAW electrodes. (Frequency
range: 10 kHz-1MHz. Signal applied: 5 mVrms.)
For gold electrodes, impedance spectra of the electrode-fluid system are
recorded from 100 Hz to 1 MHz at 5 mVrms with 0.1x PBS as measuring
solution. The measured impedance spectra together with fitted curves are
shown in Figure 5.18, with extracted circuit parameters given in Table 5.3.
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(a)

(b)

Figure 5.18 Comparison of measured impedance spectra and curve fitting of
gold electrodes. (a) Using the four element equivalent circuit; (b) Using Rf-Cint
serial connection. (Frequency range: 100 Hz-1MHz. Signal applied: 5 mVrms.)
Table 5.3 Equivalent circuit parameters obtained by curve-fitting the
experimental results for gold electrodes.
Value

Impedance
(reactance) at 100 kHz

Rct

20 kΩ

20 kΩ

Cint

120 nF

13 Ω

Rf

80 Ω

80 Ω

Cf

0.2 nF

94 kΩ

As shown in Table 5.3, at 100 kHz, the reactances for Cint and Cf are
calculated to be ~13 Ω (<<Rct) and 94 kΩ (>>Rf), respectively. Therefore, it is
also true that Cint and Rf dominate the impedance response of gold electrodes
at the frequency range of our interest.
Besides, it is worth mentioning that the impedance of the gold electrodes
after loading sample is measured to be in the range of 80-100 Ω at 100 kHz,
and the impedance analyzer used for capacitance measurement has an internal
resistance of 25 Ω. Thus, loading effect cannot be neglected for gold electrodes,
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i.e. the output voltage from the impedance analyzer is divided between the
sensor and analyzer, and the actual voltage applied onto the sensor is lower
than the nominal voltage set for the impedance analyzer. To obtain the actual
voltage drop, an oscilloscope (Agilent DSO3062A) is connected to the sensor
during measurement. The measured voltages show around 30% decrease from
the nominal measuring voltage for gold electrodes. Table 5.4 gives the actual
voltage drops corresponding to the displayed voltages on the impedance
analyzer. On the other hand, the impedance of SAW electrodes is over 1 kΩ,
so the loading effect is negligible (<2% drop).

Table 5.4 Measured voltage drop on gold electrodes.
(Unit: mVrms, rms: root mean square)
Nominal voltage

50

100

200

400

500

1000

Actual voltage

43

81

142

275

338

655

5.4.2 Simplified equivalent circuit
The above analysis shows that for the frequency range of interest to this
work (around 100 kHz), a serial connection of Rf and Cint could adequately
account for the impedance presented by the microelectrode/electrolyte system,
with

Cint

predominantly

responsible

for

the

biointeraction

process.

Correspondingly, impedance value measured by the impedance analyzer is in
the form of Zmeas = R-jX = R + 1⁄jωC

meas

, where R and X are the real part and

imaginary part of the measured impedance, respectively. From the imaginary
part, a capacitance value of Cmeas = 1⁄ωX can be found for a preset angular
frequency. Based on the above discussion of the electrode impedance spectra,
Cmeas corresponds approximately to Cint. Therefore, the change in Cmeas can be
directly used to indicate the biomolecule deposition on the electrode surface,
which greatly simplifies the process of interpreting experimental data.
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5.5. Conclusion
In this chapter, we discussed the theoretical advantages of incorporating
direct capacitive sensing with AC electrokinetics induced fluid and particle
movement, which is the capability to realize rapid real-time and label-free
detection of biomolecular interactions. We also described the two types of
sensor electrodes: SAW aluminum electrodes and gold electrodes on silicon
wafer. Furthermore, we discussed the assay procedure step by step, including
different methods of electrode surface cleaning and various options for surface
functionalization. Quality check of surface cleaning and functionalization by
reading capacitance values proves their effects. Finally, EIS characterization
showed that an Rf-Cint serial connection is able to represent the electrode-fluid
system, which further simplifies our data interpretation.
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Chapter 6. Results of analyte
detection
6.1 Sample and assay description
In this chapter, detections of different types of analytes using the ACEKbased capacitive affinity sensor are presented and discussed. As listed in Table
6.1, three types of analytes are briefly described, each of which has its own
research or realistic significances. More specifically, antibody includes antibovine IgG, Johne’s disease (JD) serum and Human& Bovine tuberculosis (hTB
and bTB) serum; virus refers to Influenza A virus; and small molecule includes
Bisphenol A (BPA) and Progesterone (PG). More of their research or realistic
significances will be mentioned when the specific assay is discussed.

Table 6.1 Target analyte description.
Types

Antibody

Virus

Description

Anti-bovine IgG

Simple and straight binding, highly

antibody

specific and sensitive [182].

Johne’s disease (JD)

One of the most economically important

serum sample

diseases of livestock [183].

Human & Bovine

A chronic infectious disease affects a

Tuberculosis(TB)

broad range of mammalian hosts

serum sample

including human and cattle [2].

Influenza A (Flu A)

One of most common causes of flu

virus sample

pandemics [184].

Small

Bisphenol A (BPA)

molecule

Progesterone(PG)

Exposure of BPA could probably cause
adverse health issues to humans[185].
Progesterone level can be an indicator
towards pregnancy [186].

Moreover, Table 6.2 provides an overview of each assay by briefly
describing the probes and target analytes, the types of sensor used, surface
functionalization method and the sample diluent of each assay. Again, more
detailed description will be provided when the specific assay is discussed.
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Table 6.2 Assay description.
Target

Sensor

Surface

analyte

used

functionalization

Bovine IgG whole

Anti-bovine

SAW and

Passive adsorption

0.1x

molecules

IgG antibody

gold

(6hrs)

PBS

JD specific

Antibody in

antigen

serum

Human/bovine TB

Antibody in

specific antigen

serum

Probes

Influenza A
antibody

Passive adsorption

SAW

Overnight (16hrs)

SAW

Spiked and
nasal swap

Sample diluent

100 % ethanol

Passive adsorption

0.1x

Overnight (16hrs)

PBS

Passive adsorption
Gold

(6 hrs) and thiol

virus

0.1xPBS

mediation (2 hrs)

Specific aptamer

Spiked BPA

SAW and

Thiol mediation

against BPA

sample

gold

(2 hrs)

Anti-progesterone

Spiked

polyclonal

progesterone

antibody

sample

0.1x PBS

Passive adsorption
SAW

(6 hrs) and APTES

0.1x PBS

treatment (5 hrs)

We start this chapter by discussing anti-bovine IgG antibody detection.
Afterwards, the detection of two types of serum antibodies (JD and TB) is
presented. Influenza A virus detection is then discussed with focus on the
usage of linker molecules. Finally, small molecule detection is discussed.

6.2 Bovine IgG antibody interaction
6.2.1 Proof-of-concept
Immunoglobulin G (IgG) is the most common type of antibody found in blood
and extracellular fluid [187], it has a well-defined “Y” structure with two available
antigen binding sites. As a proof-of-concept experiment, we study the specific
binding of goat anti-bovine IgG (H+L) antibody (unlabeled) to bovine IgG whole
molecules using our SAW electrodes. Both the bovine IgG whole molecule and
anti-bovine IgG antibody are purchased from Jackson ImmunoResearch, West
Grove, PA:


CromPure bovine IgG whole molecule, Jackson ImmunoResearch,
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cat#001-000-003, stock 10 mg/mL.


AffiPure Goat anti-bovine IgG (H+L), Jackson ImmunoResearch,
cat#101-005-003, stock 2 mg/mL.

The experimental procedure is described as follows: 10 μL of bovine IgG
whole molecules at concentration of 10 µg/mL (diluted in 0.1x PBS) is first
added on cleaned SAW electrodes as probe molecule, and the SAW electrodes
are then kept in a humidor for six hours for surface functionalization under room
temperature. After surface functionalization, the electrodes are washed with
0.1x PBST for three times and then blocked with 0.1x buffer B for 30 minutes.
The electrodes are then connected to the impedance analyzer and anti-bovine
IgG antibody samples will be introduced to the surface. Anti-bovine IgG
antibodies are tested at concentrations from 10 ng/mL to 1000 ng/mL (diluted
in 0.1x PBS). An AC signal of 100 mVrms at 100 kHz is then continuously
applied for two minutes and the corresponding capacitance change versus time
is recorded. In addition, the same experiment is repeated with doubled PBS
concentration, i.e. 0.2x PBS, which means 1 mM phosphate buffer (pH 7.0)
containing 30 mM NaCl.
Figure 6.1 presents the curves of normalized capacitance changes versus
time for three IgG concentrations in both 0.1x and 0.2x PBS. During the tests,
the interfacial capacitances changed linearly with time. No saturation or
depletion of the antibodies can be observed from these curves within the 2minute detection period. The slopes of these capacitance curves, i.e. the
fractional capacitance change rates (‰/min), are calculated as a quantitative
indication of antibodies bounded to the electrode surface. It can be seen that
the fractional capacitance change rate shows strong correlation with the
concentration of antibody. 0.1x and 0.2x PBS are test as the negative control,
which gives a change rate of 2.14 ‰/min for 0.2x PBS and -1.17 ‰/min for 0.1x
PBS. The magnitude of capacitance change consistently increases with
increasing concentration of IgG antibody. With 10 ng/mL IgG antibody, the
change rates are 12.36 ‰/min for 0.2x PBS and -6.01 ‰/min for 0.1x PBS. At
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1000 ng/mL IgG antibody, the change rates increase to 49.10 ‰/min for 0.2x
PBS and -30.72 ‰/min for 0.1x PBS.

Figure 6.1 Normalized capacitance change as a function of time within two
minutes for three different concentrations of bovine IgG antibody (10, 100 and
1000 ng/mL) in 0.1x PBS and 0.2x PBS respectively. The boxed-in numbers in
the figure are the fractional capacitance change rates of different IgG
concentrations.

It should be noted that the change of capacitance with antibody binding
can either be positive or negative. As has been theoretically discussed in
Chapter 3, we hypothesize the reason to be the difference in separation among
different probes, with the difference in their length scale comparable to EDL
thickness. Theoretically, due to the stronger ionic strength, 0.2x PBS has a
thinner EDL than 0.1x PBS. So by varying the ionic strength of buffer, it
effectively changes the relative gap between the bounded antibodies. The
results shown in Figure 6.1 support our hypothesis regarding the causes of
change in interfacial capacitance, as antibodies diluted in 0.1x PBS consistently
yields a decrease in capacitance, while antibodies diluted in 0.2x PBS yields an
increase in capacitance.
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6.2.2 Impact of electrode design on detection
In Chapter 4, we discussed ACEK and its possible effects towards binding
detection. In theory, ACEK induced fluid flow and particle movement are related
with the electrode design as well as the electric field strength being applied. In
this section, we discuss the impact of different electrode designs. The impact
of electric field strength will be discussed in the next section. Still, we use the
binding of goat anti-bovine IgG antibody (analyte) to bovine IgG (probe) to
represent the biomolecular interaction. Both of them are diluted in 0.1x PBS.
To demonstrate the impact of electrode designs on biomolecule enrichment
and detection, sensor responses from three types of electrodes are obtained
under similar electric field strength for a range of antibody concentrations.
Three sensing electrodes used are SAW electrodes (i.e. 1μm electrodes), 2μm
gold electrodes and 5μm gold electrodes on silicon wafers. The experimental
procedure is the same as described in 6.2.1. The characteristic electric field
strength for a sensor is estimated as the applied voltage divided by the half
circle over narrow electrode gap (E = 𝑉⁄𝜋𝑟, r is the distance to the center of the
electrode gap). The electric field strengths are 50 mV/μm for SAW electrodes
and 46 mV/μm for gold electrodes.
Figure 6.2 shows the responses of the three different electrodes to various
concentrations of IgG antibody samples. To account for possible artifacts from
applying electric signal to biological samples, buffer without analytes is tested
on functionalized electrodes as negative control experiments. In addition, to
demonstrate specificity, non-specific binding tests with sample solution
containing 10 ng/mL antibody are performed on un-functionalized electrodes.
Measurement at each data point is repeated three times.
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Figure 6.2 Antibody binding responses from three different electrodes under
similar electric field strength. Each test is repeated three times. Error bar
indicates the standard deviation. Control results include both buffer and nonspecific binding on un-functionalized electrodes.

As shown in Figure 6.2, the capacitance change rates are very similar
between SAW electrodes and 2μm gold electrodes for all the concentrations
tested (1, 5, 10 and 100 ng/mL), while 5μm gold electrodes exhibited much
larger responses. The SAW and 2μm gold electrodes have a logarithmic
dependence on IgG concentration ranging from 1 to 100 ng/mL. Their
sensitivities are found by linear curve fitting to be −0.59 ± 0.12 and −0.49 ±
0.07 %/log (ng/mL) with a Pearson correlation coefficient R2 [188] of 0.88 and
0.94 for SAW and 2μm gold electrodes, respectively. In comparison, 5μm gold
electrodes yield a sensitivity of −1.80 ± 0.69 %/log (ng/mL), more than three
times that of SAW and 2μm gold electrodes. The 5μm gold electrodes exhibit
logarithmic dependence on IgG concentration from 1 to 10 ng/mL, however,
there is no increase in sensor response when the IgG level becomes higher
than 10 ng/mL, probably due to saturation of binding sites by strong ACEK
enrichment. As the electric field strengths are similar between the electrodes,
so the differences between their output magnitudes can only be attributed to
the electrode geometric differences. According to Eqns (4.1) and (4.2), DEP is
more pronounced with smaller electrodes, while ACET effect favors larger
microelectrodes. Since SAW and 2μm gold electrodes have similar output, it
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may be concluded that DEP and ACET effect are comparable for electrodes
with a characteristic size of 2μm and less. While for larger electrodes, ACET
force will dominate, which is demonstrated by the significant improvement in
the sensitivity of 5μm gold electrodes over 2μm electrodes.
Relatively speaking, the negative control experiments using blank buffer
exhibit very little responses. SAW electrodes, 2μm gold electrodes and 5μm
gold electrodes show capacitance change rates of 0.01 ± 0.09 %/min, −0.03 ±
0.03 %/min and 0.21 ± 0.05 %/min, respectively. The outputs of non-specific
binding tests on un-functionalized electrodes are a little larger, but still show
little capacitance changes, −0.19 ± 0.10 %/min for SAW electrodes, −0.09 ±
0.03 %/min for 2μm gold electrodes and −0.26 ± 0.01 %/min for 5μm gold
electrodes, which attests to the specificity of our tests. Also, based on Figure
6.2, sensor output more positive than −0.30%/min is defined as being nonreactive, i.e. negative response.
6.2.3 Impact of electric field strength
The impact of the applied electric field strength on IgG antibody binding
detection is studied in this section using gold electrodes, with AC electric field
strength ranging from 13 mV/μm to 86 mV/μm. This helps to establish a range
of electric field strength for effective improvement by ACEK effects. Binding
detection results of 10 and 100 ng/mL IgG antibodies on both 2μm and 5μm
gold electrodes are shown Figure 6.3.
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Figure 6.3 Binding responses of control buffer, non-specific, 10 ng/mL and
100 ng/mL IgG samples under different electric field strengths. Both 2μm and
5μm gold electrodes are tested for comparison. Each test is repeated twice
and the error bar indicates standard deviation.
From Figure 6.3, it is first noted that at 13 mV/μm, the sensor responses are
small for all cases, even for 100 ng/mL sample on 5μm gold electrodes. This
indicates that this electric field strength is too low to induce sufficient ACEK
effects to effectively enhance binding reactions. For 5μm gold electrodes, the
change rates are slightly more negative than −0.30%/min, the cut-off point for
a detection. Second, it is evident that the capacitance change rate increases
steadily with electric field strength, indicating that binding is aided by AC electric
field, which strongly supports that AC electric field can induce usable DEP and
ACET effects. Third, the difference in the responses between 2μm and 5μm
gold electrodes widens quickly at higher electric field strength, which is
consistent with Eqn (4.2) of ACET force 𝐹𝐴𝐶𝐸𝑇 ∝ 𝑟|𝐸|4 , especially for responses
to 10 ng/mL antibody samples. So it is clear that enrichment by ACET effect is
more dominant in larger electrodes. Last, the rate of increase in sensor
response becomes less when the electric field strength goes above 45 mV/μm,
especially for 5μm gold electrodes. So the range of AC electric field strength
can be estimated to be between 13 and 45 mV/μm for effective induction of
ACEK enhancement in affinity sensing.
Furthermore, it should be noted that if the electric field strength is higher
than 45 mV/μm, ACEK effects become so strong that sufficient analyte
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molecules are transported close to the electrodes, and the surface binding
shifts from transport-limited domain to reaction-limited domain. The outputs
from 5μm electrodes are strongly indicative of saturation of binding sites. There
is little difference between its response to 10 and 100 ng/mL IgG samples, and
there is no increase in sensor response at electric field higher than 45 mV/μm.
A comparison of the output transients between 2μm and 5μm gold
electrodes shows that ACET flows are the cause of binding saturation, as
shown in Figure 6.4. For 2μm gold electrodes at 86 mV/µm, as shown in Figure
6.4a, the decrease in capacitance consistently becomes larger with more
concentrated IgG samples. The interfacial capacitance decreases linearly with
time with little indication of saturation.

However, for 5μm gold electrodes,

saturation begins to show for IgG above 10 ng/mL even at 45 mV/μm. The
change rate in normalized capacitance becomes larger as IgG concentration
increased from 1 ng/mL to 5 ng/mL and 10 ng/mL. For 100 ng/mL, the
capacitance initially dropped quickly then became more gradual after 10
seconds, which is indicative of slowdown in binding reaction. At 86 mV/μm, the
indication of saturation kinetics became much more pronounced. The
capacitance curves for 10 ng/mL and 100 ng/mL overlap each other and
asymptotically approach a maximum of capacitance change, which is
characteristic of specific binding.
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2μm electrode @ 86 mV/μm

(a)

5μm electrode @ 45 mV/μm

5μm electrode @ 86 mV/μm

(b)
(c)
Figure 6.4 Normalized capacitance change with time. (a) 2μm electrodes
measured at 86 mV/µm; (b) 5μm electrodes measured at 45 mV/µm; (c) 5μm
electrodes measured at 86 mV/µm.
ACET effect is expected to be more obvious for detecting diluted analyte
since longer range of enrichment is involved. In fact, sample enrichment is more
highly desired for diluted samples. Table 6.3 shows the capacitance change
rate of 1 and 5 ng/mL IgG sample at 10-second time periods. It can be seen
clearly that binding events change from transport-limited for 2μm gold
electrodes or at lower electric field to reaction-limited at higher electric field for
5μm gold electrodes. In the first 10 seconds, 2μm gold electrodes show a
capacitance change rate of 0.40 %/min. As time goes by, the change rate
becomes more negative from −0.29 %/min in 10-20 seconds to −0.82 %/min
in 20-30 seconds, which indicates increasing binding rate as a result of
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biomolecules being gradually transported to the vicinity of electrode surface.
Similar situation is shown for 5μm gold electrodes at 45 mV/μm. In comparison,
it is a different scenario for 5μm gold electrodes at 86 mV/μm. At 1 ng/mL, its
change rate is −1.13 %/min in the first 10 seconds and slows down in
subsequent time periods, indicating a faster transport of analytes at 86mV/μm
than at 45 mV/μm. At 5 ng/mL, the Cint change rate is fairly constant, probably
because there are plenty of analytes for binding. It is clear from Table 6.3 that
larger electrodes are better at enriching analytes and the enrichment effect is
caused by AC electric field. Both the much larger response and its transient
behavior of 5μm gold electrodes indicate that 5μm gold electrodes can induce
much stronger ACEK effect, mostly ACET effect, to enhance detection of more
diluted analytes.

Table 6.3 dC/dt (%/min) of 1 and 5ng/mL for every 10 seconds.
Conditions

0-10 sec.

10-20 sec.

20-30 sec.

2μm@86 mV/μm (1 ng/mL)

0.40

-0.29

-0.82

5μm@45 mV/μm (1 ng/mL)

-0.04

-0.67

-1.53

5μm@86 mV/μm (1 ng/mL)

-1.13

-0.56

-0.66

5μm@86 mV/μm (5 ng/mL)

-0.90

-1.42

-1.37

From a physics viewpoint, electric field of 2μm or smaller electrodes is
concentrated around the electrode corners and between the electrodes, while
electric field of 5μm electrodes could reach further into the fluids. ACET effect,
as a body force, need some distance away from solid phase to effectively
generate convection [189]. Otherwise, the friction from the solid surface will be
overwhelming (no slip boundary condition). Consequently, 5μm electrodes is
able to generate much stronger ACET convections than 2μm electrodes, which
in turn provides a much larger signal.
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6.2.4 Determination of LOD
With the limit of detection (LOD) being defined as more than three standard
deviations from that of control tests, the LODs of SAW and 2μm gold electrodes
are found to be 10 ng/mL (their capacitance change rates at 10 ng/mL are
−0.50 ± 0.04 %/min and−0.50 ± 0.04 %/min. In contrast, 5μm gold electrodes
showed a change rate of −0.60 ± 0.13 %/min for 1 ng/mL IgG sample. So the
LOD for 5μm gold electrodes is 1 ng/mL, increasing by approximately one order
of magnitude from SAW and 2μm gold electrodes.

6.3 Detection of antibody in serum
In this section, we will move on to the detection of more complex serum
samples. Serum is a blood component collected after blood has coagulated. It
contains various types of proteins, including antibodies [190]. In this work, three
types of serum samples with realistic significances are tested: Johne’s disease
(JD) serum sample, human tuberculosis (hTB) serum sample and bovine
tuberculosis (bTB) serum sample.
Johne’s disease is a chronic disease of mainly ruminants leading to
granulomatous enteritis, persistent diarrhea, progressive wasting and finally
death [191, 192]. The disease is distributed globally among domestic ruminants
and wildlife species [193, 194].
Tuberculosis (TB) is also a chronic infectious disease that affects a broad
range of mammalian hosts including humans and cattle. Human TB is
estimated to cause more than two million deaths every year. Although bovine
TB, caused by Mycobacterium bovis, has been mostly eradicated in the
livestock industry of developed countries, the disease in wildlife still poses a
risk to livestock, tourism economy, and wildlife conservation. Global economic
losses from bovine TB total US$ 3 billion annually. In developing countries,
bovine TB still causes serious concerns not only for wildlife, but also for public
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health, food safety and the economy of livestock industries.
Conventional methods of chronic diseases diagnosis are labor-intensive,
time-consuming and/or expensive. For example, medical evaluation of human
TB includes a medical history, physical examination, radiographic imaging
(conventional chest X-ray), microbiological smears, and bacterial cultures. It
may also include a tuberculin skin test or other measurements of cellular
immunity, such as interferon-gamma release assays (IGRA). For human TB,
the Cepheid Xpert MTB/RIF assay has recently been used for on-site diagnosis
but the assay is costly [195, 196]. Bovine TB in animals is commonly confirmed
by post mortem examination of gross lesions and bacterial culture. Global
control and prevention of TB has partly been hampered by the lack of effective
diagnostic methods, so there is an urgent need for more simple, rapid and
sensitive on-site diagnosis of TB [5].
It should be noted that both JD and TB serum samples are composed of
mixtures of complex fluids, hence the exact antibody concentrations of these
complex serum samples are unknown.
6.3.1 Sample preparation
6.3.1.1 Johne’s disease antigen and serum samples

The preparation of Johne’s disease specific antigen and serum samples is
described as follows:


Johne’s

disease

(JD)

specific

antigen:

A bacterial

pathogen

Mycobacterium avium subsp. paratuberculosis (MAP), which is the
causative agent of JD, is used to extract antigen as described previously
elsewhere [197]. MAP is obtained from Dr. John P. Bannantine in the
USDA/NADC (Ames, IA) and is cultured in Middlebrook 7H9 medium
(Becton Dickinson Microbiology Systems, Franklin Lakes, NJ) with 10%
OADC (oleic acid-albumin-dextrose-NaCl) (Becton Dickinson Microbiology
Systems, Franklin Lakes, NJ). The medium is supplemented with 2 µg/mL
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of Mycobactin J (Allied Monitor, Fayette, MO). The cultures are maintained
at 37°C without shaking until they reach an optical density of approximately
0.7 at 600 nm. MAP is harvested from the liquid culture at stationary phase
and centrifuged at 2,600 × g for 10 minutes; the pellet is resuspended in
80 % ethanol, agitated by vortex at room temperature for 2 minutes, and
centrifuged at 10,621× g for 10 minutes. The supernatant is then collected,
diluted in 100 % ethanol (1:80 v/v) and used as antigen for this assay.


Johne’s disease serum sample: Ten JD-positive serum samples are
obtained from 10 different dairy cows (breed: Holstein; average age: 2.8
years old; gender: female) tested positive for JD by bacterial culture and
ELISA [171]. Ten JD-negative serum samples are obtained from 10 different
cows (breed: Holstein; average age: 2.4 years old; gender: female) tested
negative for JD by the procedures mentioned above. The bovine serum
samples used in this work are kindly provided by National Animal Disease
Center, USDA, Ames, IA. For testing, the serum samples are diluted with
0.1x PBS before use.

6.3.1.2 Human and Bovine tuberculosis specific antigens and serum samples

The preparation of human and bovine tuberculosis specific antigens and
serum samples is described as follows:


Human tuberculosis (hTB) specific antigen: Purified protein derivative
(PPD) of Mycobacterium tuberculosis (Accurate Chemicals, NY) is adopted
as the probe molecule and immobilized at a concentration of 10 µg/mL
(diluted in 0.1x PBS).



hTB serum samples: A total of 11 human serum samples are obtained
from the WHO (World Health Organization/Tropical Diseases, Special
Programme for Research and Training) and tested for hTB. Six of these
samples are obtained from patients tested positive for hTB based on prior
TB history and bacterial culture results. Five of these samples are obtained
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from patients tested negative for hTB based on the above mentioned tests.
Serum samples are diluted in 0.1x PBS before testing.


Bovine tuberculosis (bTB) specific antigen: A virulent strain of
Mycobacterium bovis (HC2005T), which is originally isolated from an M.
bovis infected dairy cow, is cultured in Middlebrook’s 7H9 medium with
addition of 0.05% Tween 80, 10% oleic acid-albumin-dextrose-NaCl at 37℃.
For antigen preparation, M. bovis bacilli is harvested from stationary phase
cultures, suspended in 80% ethanol (80 mg wet weight of bacteria/mL) and
agitated by vortex to dislodge surface antigens. The dislodged M. bovis
antigen is diluted (1:80) in the ethanol solution and used as antigen in this
assay.



bTB serum samples: A total of 10 badger serum samples are provided
by Animal Health and Veterinary laboratories Agency (AHVLA), UK. The
bovine TB positive samples (n=5) are obtained from badgers which had
previously tested positive for M. bovis by bacterial culture from clinical
samples collected ante mortem and by ELISA for interferon-gamma. The
negative serum samples (n=5) are obtained from animals from a region of
the UK considered free from M. bovis infection in badgers and which are
confirmed to be negative for bTB through repeat testing by the procedures
mentioned above. Serum samples are diluted in 0.1x PBS before testing.

6.3.2 Proof-of-concept
For proof-of-concept, one of each of the JD positive and negative samples
are tested using SAW electrodes to demonstrate the capability of distinguish
serum positive/negative samples. The experimental procedure is described as
follows: 10 μL of JD specific antigen is coated on cleaned SAW electrodes for
overnight (16hrs) under room temperature, then the functionalized electrodes
are washed with 0.1xPBST for three times and blocked with 0.1x buffer B for
30 minutes. JD negative serum sample is diluted in 0.1x PBS with a volume
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ratio of 1:20, while JD positive serum sample is diluted with 0.1x PBS with a
volume ratio from 1:20 to 1:200 dilution for proofing quantitative detection as
well. An AC signal of 100 mVrms at 100 kHz is continuously applied as the
measuring signal for 200 seconds.
Theoretically,

disease

positive

serum

samples

contain

higher

concentrations of antibodies that will specifically bind to the antigens from the
causative agent of the disease. Therefore, disease positive serum samples
should exhibit larger change of Cint than disease negative samples.
The normalized capacitance change rates for various dilutions of JD positive
sera are plotted in Figure 6.5, negative serum sample and buffer are tested as
control groups. The slopes of these capacitance curves, i.e. capacitance
change rates, are also shown in the plot. As shown in Figure 6.5, the
capacitances of JD negative serum sample and PBS stay rather constant
during the test, while that of JD positive serum sample decreases monotonically
with time due to specific recognition of serum antibodies. For the positive
sample diluted at 1:20, the capacitance change rate reaches −54.6 ‰/min.
While for negative sample and PBS, the related numbers are only −1.6 ‰/min
and −2.6 ‰/min , respectively. The low capacitance change rate of the
negative sample indicates that signal interferences from non-specific
interactions are at a very low level.
Furthermore, as expected, when the sample becomes more diluted, the
capacitance change rate decreased from −54.6 ‰/min at 1:20 dilution to
−1.1 ‰/min at 1:200 dilution. Highly diluted sera (e.g. 1:160 dilution and 1:200
dilution) cannot be differentiated from the control tests. For JD positive serum
samples with dilution from 1:120 to 1:40, the normalized capacitance change
rate shows a logarithmic dependence on serum dilution. The dependence could
be expressed as:
y (‰⁄𝑚𝑖𝑛) ≈ −73.7 log (serum dilution) − 157.5,

(6.1)

with Pearson correlation coefficient R2=0.912. The results demonstrate that the
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ACEK-based capacitive affinity biosensor is a quantitative method within a
range of antibody concentrations.

Figure 6.5 Transient behavior of normalized capacitances of JD serum
samples. The samples are various dilutions of JD positive sera (1:20 to
1:200), negative sera (1:20) and 0.1x PBS (control).

6.3.3 Signal optimization
Furthermore, as discussed in the detection of bovine IgG antibody, if the
short “sample to results” time is a result of AC electrokinetics enrichment, then
the capacitance change rate should exhibit a certain dependence on the
applied AC signal. Therefore, as a reinforcement to the proof-of-concept
experiments, binding of JD positive serum samples are tested under different
AC signals using SAW electrodes, following the same experimental procedure
described before.
Firstly, the frequency of the signal is fixed at 100 kHz while the amplitude is
varied from 5 mVrms to 500 mVrms. The capacitance change rates are
obtained and plotted in Figure 6.6a as a function of voltage amplitude. As could
be seen, with JD positive serum, the capacitance change rate increases
monotonically with the magnitude of AC signals. The change rates from the
positive sample are significantly higher than those from the control samples
except for the results at 5 mVrms, while the change rate remained consistently
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low (< ±3.7 ‰/min) for the control experiments (0.1x PBS) during the same
voltage range. It indicates that 5 mVrms is too low to induce any ACEK effects
to enhance specific biointeractions between antigens and antibodies. With 5
mVrms applied, the capacitance change rate is merely −5.2 ± 0.8 ‰/min, only
slightly higher than that of the control samples, which is −3.7 ± 2.1 ‰/min.
Such a small difference between JD positive serum sample and the control
sample would not warrant an accurate detection of specific binding. Meanwhile,
the capacitance change rate increases rapidly when the applied voltage
increased from 5 mVrms to 100 mVrms. The change rate of capacitance at 50
mVrms is −29.1 ± 0.4 ‰/min , while 100 mVrms yields a change rate
of −54.6 ± 2.1 ‰/min. The increase in capacitance change rate slows down
when the voltage goes above 100 mVrms, which could be caused by possible
adverse effect that electric field may have on the activities or adhesion of serum
antibodies. Nevertheless, the increase of capacitance change rate with voltage
amplitude serves to corroborate the contribution of ACEK effect in this
capacitive assay. The results in Figure 6.6a also let us set 100 mVrms as the
optimal operating voltage of serum antibody detection. Additionally, the control
solution consistently exhibited low capacitance change rates throughout the
voltage range, indicating that the high response from positive sample is not
caused by electrochemical reactions or other impedimetric artifacts in the
measurement.
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Figure 6.6 Capacitance change rates of JD positive serum sample and control
buffer (0.1X PBS) when they are tested at (a) 100 kHz AC signals of various
voltage amplitudes, (b) 100 mVrms AC signals at different frequencies. Each
data point shows the average of three tests. Error bar indicates the standard
deviation.
Secondly, as DEP force is frequency dependent, there should exist a
specific frequency at which the target macromolecules will experience maximal
attraction force to the electrodes (i.e. the strongest positive DEP). The
accompanying ACET flows may add to the particle movement caused by DEP,
but will not affect its frequency properties, since ACET effect is independent of
AC frequency until a certain level [198, 199]. This time, binding experiments of
JD positive antibodies are conducted at different frequencies at a fixed
amplitude of 100 mVrms.
The capacitance change rates at different frequencies (ranging from 5 kHz
to 5 MHz) are plotted in Figure 6.6b, which demonstrate a strong frequency
dependency. The change rate is largest between 100 kHz and 300 kHz, and
quickly dropped when AC frequency is deviated from this frequency range. The
bell-shaped frequency dependence clearly indicates DEP characteristics.
When AC frequency is outside the optimal range, the capacitance change rates
are still much higher than those of control sample (in contrast to the results of
5 mVrms assay), which could be attributed to ACET microflows.
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6.3.4 Detection results of serum samples
6.3.4.1 Johne’s disease

As described before, a total of twenty JD serum samples are tested using
SAW electrodes: ten positive samples and ten negative samples. An AC signal
of 100 mVrms, 100 kHz is employed as the measuring signal for two minutes.
The corresponding capacitance change rates are calculated and plotted in
Figure 6.7, which demonstrating a clear differentiation between capacitance
changes in JD-negative and JD-positive samples by using a cut-off value of 10.0 ‰/min.

Figure 6.7 Detection results of Johne’s disease serum samples.

Moreover, the repeatability test is also conducted by measuring one positive
serum sample on five different sensor electrodes, with results shown in Figure
7.2. The calculated coefficient of variation (CV) [200] is only 12.7%,
demonstrating decent repeatability.
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Figure 6.8 Repeatability test with JD positive sample. Same positive sample is
tested five times on five different SAW electrodes.

6.3.4.2 Human and Bovine tuberculosis

11 Human TB serum samples (6 positive and 5 negative) and 10 Bovine
TB serum samples (5 positive and five negative) are tested using SAW
electrodes. The experimental procedure is described as follows: 10 μL of
hTB/bTB specific antigens are coated on cleaned SAW electrodes for overnight
(16hrs) under room temperature, then the functionalized electrodes are washed
with 0.1xPBST for three times and blocked with 0.1x buffer B for 30 minutes.
Both hTB and bTB serum samples are diluted in 0.1x PBS with a volume ratio
of 1:20 prior to loading.
Before testing the serum batch, the frequency of the applied AC signal is
optimized by testing a positive hTB serum sample with 100 mVrms AC signals
at 10, 20, 50, 100, 200 kHz and 1 MHz on different electrodes Except for 100
kHz, responses from five of the AC frequencies average around ~10.0 ‰
change in Cint, while 100 kHz AC signal yields ~ 50.0 ‰ change. As a result,
an AC signal of 100 mVrms at 100 kHz is applied to be the optimal test
frequency for TB serum samples. Testing time is one minute for each sample.
The results of TB detection using capacitive sensing are shown and
confirmed with the results of ELISA in Figure 6.9 and 6.10. 0.1x PBS is tested
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as the control sample.
Capacitive sensing of hTb

ELISA of hTb

Figure 6.9 Capacitive sensing vs. ELISA of human TB (hTB) positive and
negative serum samples. (P: positive samples, N: negative samples; C:
control buffer)
Capacitive sensing of hTb

ELISA of hTb

Figure 6.10 Capacitive sensing vs. ELISA of bovine TB (bTB) positive and
negative serum samples from badgers. (P: positive samples, N: negative
samples; C: control buffer)
As could be seen, disease-positive sera always exhibit large responses
than disease-negative samples, which is consistent with the fact that diseasepositive serum samples have higher concentrations of disease-specific
antibody. Also, two types of control experiments are conducted. One, as shown
in Figures 6.9 and 6.10, uses functionalized electrodes with serum-free buffer.
Another control experiment (data not shown in the figure to avoid confusion)
uses un-functionalized electrodes (blocked but without antigen) with positive
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serum samples. The control experiment shows little changes in Cint, which
is −2.4 ± 1.1 ‰/min, demonstrating the specificity.
The fact that bovine TB shows negative changes in capacitance while
human TB shows positive changes could be explained by referring to Chapter
3. Suppose bounded hTB antibodies have larger separation from each other
than that of bound bTB antibodies, and then consequently hTB samples would
lead to an increase of interfacial capacitance after binding, while bTB samples
would lead to decreased interfacial capacitance after binding.
Again, to demonstrate the repeatability of the ACEK-based capacitive
sensing method, one bTB-positive and one bTB-negative serum sample are
tested on five different SAW electrodes for a total of ten chips. The test results
and their respective CVs are shown in Table 6.4. The CV for bTB-positive serum
is calculated to be 9.2%, showing good repeatability. The CV for bTB-negative
serum is expected to be larger since the response of negative sample is
relatively small.

Table 6.4 Repeatability test with bTB samples. Each sample is tested five
times on five different chips.
Samples
bTBpositive
bTBnegative

Chip 1

Capacitance change rate (‰/min)
Chip 2
Chip 3
Chip 4
Chip 5
STD

CV

-21.5

-29.5

-27.1

-25.9

-27.0

2.4

9.2%

-2.4

-3.4

-2.0

-1.7

-3.1

0.6

23.3%

6.4 Influenza A virus Detection
Influenza (Flu) is a contagious respiratory infection caused by a variety of
flu viruses [201]. There are three types of flu viruses: A, B and C [202]. Type A
flu virus is the most commonly cause of large flu epidemics, it is capable of
infecting both humans and animals. Compared with type A, type B can only
affect humans and it is usually less common and severe. Type C can also cause
flu symptoms but are much less severe compared with flu A and B. In this work,
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we focus on the detection of Influenza A virus using our capacitive affinity
sensor.
6.4.1 Sample preparation
Influenza A antibody: mouse monoclonal Influenza A antibody (H1NI,
isotype: IgG2a) is provided by Meridian Bioscience, Inc. In this work, antibody
is diluted in 0.1x PBS.
Influenza A virus (clean standard): purified and inactivated Influenza A
antigen strain (H3N2) cultured in embryonated chicken eggs are provided by
Meridian Bioscience, Inc. In this work, virus samples (diluted in 0.1x PBST) of
three concentrations are tested: 10, 100 and 1000 ng/mL. Tween 20 is added
to help to release the available binding sites of the virus.
Influenza A virus (nasal swab): clinical nasal swab samples containing
Influenza A viral particles are provided by Meridian Bioscience, Inc. In this work,
clinical sawb samples are diluted in 0.1x PBST.
6.4.2 Specificity
Influenza A (Flu A) detection is performed using 2μm gold electrodes. The
experimental procedure is described as follows: 10 μL of antibody at
concentration of 200 ng/mL (diluted in 0.1x PBS) is first added on cleaned
electrodes as probe molecule, and the electrodes are then kept in a humidor
for six hours for surface functionalization under room temperature. After surface
functionalization, the electrodes are washed with 0.1x PBST for three times and
then blocked with 0.1x buffer B for 45 minutes. The electrodes are then
connected to the impedance analyzer and Influenza A virus samples will be
introduced to the surface. Samples are tested at concentrations from 10 ng/mL
to 1000 ng/mL (diluted in 0.1x PBST). An AC signal of 10-100 mVrms at 100
kHz is then continuously applied for 30 seconds and the corresponding
capacitance change versus time is recorded.
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One of the biggest concerns in Flu A detection is whether the detected
signal is from a specific biointeraction. In reality, most clinical samples are
complex, which means both type A and B viruses can exist at the same time.
As a result, there are chances that cross reactivity might take place and
interfere with the detection. To verify the specificity of our capacitive affinity
assay, four different scenarios are designed and tested, as shown in Figure
6.11:
1. True positive: Flu A antibody functionalized chips tested with Flu A virus.
2. Cross reactivity: Flu A antibody functionalized chips tested with Flu B
virus.
3. True negative: Flu A antibody functionalized chips tested with buffer.
4. Non-specific: Unfunctionalized chips tested with Flu A virus.

Figure 6.11 Specificity test of Influenza A: four different scenarios.

Figure 6.12 shows the capacitance change rates of the four cases under
two different voltage levels: 10 mVrms and 100 mVrms. The initial test plan is
to apply 100 mVrms, yet it is found that the non-specific signal at 100 mVrms
reaches −0.49 ± 0.16 %/min, which is very close to the specific binding signal
of true positive ( −0.66 ± 0.11 %/min ). It indicates that the ACEK induced
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particle and fluid movement might be excessive. To prove our hypothesis, a
much lower signal, 10 mVrms, is applied and the same test is performed again.
As expected, non-specific signal at 10 mVrms is reduced to −0.23 ±
0.05 %/min, while specific binding signal remains at a relatively high level
(−0.48 ± 0.10 %/min). In addition, it is exciting to see that cross reactivity
signals stay at low level for both 10 mVrms (−0.06 ± 0.02 %/min) and 100
mVrms ( −0.23 ± 0.07 %/min ), proving the specificity of the ACEK-based
capacitive affinity sensing.

Figure 6.12 Capacitance change rates for the four scenarios under 10 and
100 mVrms. Each data point is the average of three repeated tests. Error bar
indicates standard deviation.

6.4.3 Effect of linker molecules
So far, for the assays we have described (bovine IgG antibody, JD, TB and
Influenza A), only passive adsorption has been applied as the surface
functionalization method. In Chapter 5, we mentioned that using linker
molecules could possibly facilitate surface functionalization by forming strong
and uniform probe coating, hence the sensor is expected to show better
sensitivity and stability.
In the detection of Influenza A, sensors functionalized with passive
adsorption are found to show some instable results, especially for high
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concentration samples. Table 6.5 listed the capacitance change rates of 1000
ng/mL virus sample from five different sensors. As can be seen, for the same
sample, the highest response reaches −0.9 %/min, while the lowest response
is only −0.29 %/min. Moreover, CV is calculated to be 45%, which is obviously
out of the usable range (normally <15% is required). Therefore, for the purpose
of improving sensing stability and repeatability, the usage of linker is introduced
for Influenza A detection.

Table 6.5 Repeatability test with flu A virus. 1000 ng/mL virus sample is tested
five times on five different chips.
Samples
Flu A virus
(1000 ng/mL)

Chip 1
-0.47

Capacitance change rate (%/min)
Chip 2
Chip 3 Chip 4 Chip 5
STD
-0.97

-0.90

-0.42

-0.29

0.28

CV
45%

As described before, thiol linker molecules have strong affinity towards
gold electrodes. In this work, thiol linker (3-MPA) is applied on 2μm gold
electrodes for surface functionalization following the procedure described in
Chapter 5. After the formation of thiol SAM, antibody is added to the surface for
two hours in a humidor under room temperature. Blocking and analyte detection
procedures are the same as described in 6.4.2. An AC signal of 10 mVrms at
100 kHz is applied as the measuring signal for 30 seconds, with capacitance
change results shown in Figure 6.13.
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Figure 6.13 Flu A detection results: passive adsorption vs. thiol linker. Each
data point is the average of five repeated tests. Error bar indicates standard
deviation.
In Figure 6.13, it is clear that binding responses get much more stable with
linker functionalized sensors: for example, at 1000 ng/mL, the capacitance
change rate is −0.61 ± 0.27 %/min for passive adsorption, which is improved
to −0.83 ± 0.09 %/min for linker functionalized sensors. It demonstrates
higher responses while lower instability, which proves the effectiveness of using
thiol linker molecules. Moreover, the binding sensitivity is also improved from
−0.21 ± 0.15 %/log(ng/mL) to −0.48 ± 0.10 %/ log(ng/mL) when thiol linker
is applied for surface functionalization.
6.4.4 Blocking optimization
As mentioned in Chapter 5, the purpose of surface blocking is to cover the
open spaces on the electrodes to minimize non-specific deposition of
bioparticles. In the detection of Influenza A, various blocking methods are
adopted. Based on the binding responses from flu A virus samples, their effects
are briefly concluded in Table 6.6.
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Table 6.6 Descriptions of various blocking methods and major conclusions.
Blocking reagent

Time

Temperature

Conclusions

Commonly used blocking plan in
0.1x buffer B

30 mins

RT

affinity biosensing. Works fine
with Influenza A detection.

0.1x buffer B

45 mins

RT

0.1x buffer B

1 hr

RT

0.1x buffer B

1 hr

37℃

1x buffer B

30 mins

RT

1x buffer B

1 hr

RT

2 v/v% BSA

30 mins

RT

Slightly better at reducing nonspecific responses.
No clear difference compared
with 45 mins blocking.
No clear difference compared
with RT.
Too strong, specific response is
reduced a lot.
Too strong, specific response is
reduced a lot.
Too strong, specific response is
reduced a lot.
Works fine with Influenza A

0.2 v/v% BSA

30 mins

RT

detection, but not showing any
better than 0.1x buffer B.

From Table 6.7, it is concluded that a 45 minutes blocking with 0.1x buffer B
under room temperature yields the optimal binding response. It is therefore
chosen to be the blocking method for influenza A detection.
6.4.5 Blind test of clinical swab samples
Twenty clinical swabs samples collected from different patients are provided
by Meridian Bioscience Inc. The identities of the samples are confirmed by PCR
(Cepheid Xpert [203]), yet they are not informed before being tested by the
ACEK-based capacitive affinity sensor. Prior to detection, these swab samples
are diluted 1:1000 v/v% in 0.1x PBST.
Table 6.7 listed and compared the results obtained by the capacitive affinity
sensing method with the PCR confirmed results. Out of the twenty samples,
only four of them are detected wrongly (in red) and one of them is called to be
undetermined by both methods (in orange). The overall success rate reaches
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79% (15/19), which is very promising.

Table 6.7 Blind test results of twenty clinical swab Influenza A samples.
dC/dt

Capacitive sensing

PCR results provide by

(%/min)

results

Meridian Bioscience Inc.

No.1

1.57

N

N

No.2

-1.59

P

N

No.3

-2.14

P

P

No.4

0.43

N

P

No.5

-0.17

N

N

No.6

0.05

N

N

No.7

-1.83

P

P

No.8

3.78

N

N

No.9

-3.71

P

P

No.10

-0.50

?

P

No.11

0.76

N

N

No.12

-3.03

P

P

No.13

-1.39

P

N

No.14

0.53

N

N

No.15

-0.56

?

?

No.16

1.01

N

N

No.17

-0.86

P

P

No.18

-3.44

P

P

No.19

-0.96

P

P

No.20

-1.24

P

P

Sample

6.5 Small molecule detection
As the name implies, small molecule refers to biomolecules which sizes are
on the order of nm (low molecular weight, < 900 Da). For example, the
molecular weight of BPA is only 228 Da, while for anti-bovine IgG antibody, the
molecular weight is 150 kDa. In this work, two types of small molecules with
biological significances are tested in their spiked form: Bisphenol A and
progesterone.
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Bisphenol A (BPA) is an industrial chemical used as an intermediate to make
polycarbonate plastic, epoxy resins and many other specialty products [204]. It
can be found in many of daily used items including water bottles, food
containers, and paper products for decades [205]. Yet recent studies have
found the exposure of BPA could probably cause adverse health issues to
humans [185, 206]. It is reported that BPA is an endocrine-disrupting chemical
and its estrogenic activity could affect different organs [207]. Thus detection of
BPA level within the environment as well as human serum is of crucial
importance. Current BPA detection methods include high performance liquid
chromatography

(HPLC)

[208,

209]

and

gas

chromatography-mass

spectrometry (GC-MS) [210, 211]. While good detection limits were reported,
e.g. 0.04 ng/mL by HPLC, these methods require the use of sophisticated and
costly instruments by skilled personnel, and yet the operation is complex and
time-consuming. Therefore, a simple, affordable and label-free method to
monitor BPA level in environmental samples is highly desired.
Progesterone is a hormone produced mainly in the ovaries. In pregnancy,
after an ovum is released, progesterone helps make the uterus ready for
implantation of a fertilized ovum and prepares the uterus for pregnancy and the
breasts for milk production [212]. In dairy industry, pregnancy test is an
important management measure to keep cattle producing milk with minimized
open (non-lactating) period [213, 214]. Currently, pregnancy tests are
conducted by either transrectal palpation or immunoassay in diagnostic
laboratory. Previous studies indicated that palpation in early gestation
increased risk of embryonic mortality [215]. Current format of immunoassay for
progesterone is enzyme-linked immunosorbent assay (ELISA), which requires
the use of laboratory equipment and several hours of labor. Comparing with the
current format, ACEK-based capacitive affinity sensing is expected to obtain
better sensitivity in shorter time, with less sensor preparation and sample
processing.
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6.5.1 Sample preparation
6.5.1.1 Bisphenol A

The preparation of BPA specific aptamer and spiked BPA sample is
described as follows:
BPA specific aptamer: The specific aptamer with 5’ thiol modifier C6



SH is synthesized by Sangon Biotech (Shanghai) Co., Ltd. The
sequence of the aptamer (5’ to 3’) is 5’-CCG GTG GGT GGT CAG GTG
GGA TAG CGT TCC GCG TAT GGC CCA GCG CAT CAC GGG TTC
GCA CCA-3’. In this work, aptamer is diluted in 0.1x PBS.


Spiked BPA sample:

4, 4’-Isopropylidenediphenol

(BPA) is

purchased from Fisher Scientific, Pittsburgh, PA. Dimethyl Sulfoxide
(DMSO), ≥99.7% is also purchased from Fisher Scientific, which is
used as the solvent for BPA. 0.1x PBS is used for the dilution of BPA.


Triton X-100 stock solution is purchased from Alfa Aesar, Ward Hill,
MA, which is used as the blocking buffer.

6.5.1.2 Progesterone

The preparation of anti-PG antibody and spiked PG sample is described as
follows:


Anti-progesterone polyclonal antibody (Fisher Scientific, PA175366),
Host Species: Sheep Species Reactivity: Chemical Immunogen:
Progesterone (11)-BSA 100 µL; Unlabeled 100 µL). In this work, purified
anti-progesterone polyclonal antibody is diluted in 0.1x PBS.



Spiked progesterone: Acros Organics (thru Thermo Fisher Scientific
[Pittsburg, PA] #225650050), stock 10 mg/mL in DMSO. In this work,
progesterone is diluted in 0.1x PBS.
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6.5.2 Detection of BPA
The detection of BPA is performed using both SAW and gold electrodes,
with procedures described as follows: cleaned electrodes are functionalized
with thiol modified aptamer (0.1 μM, diluted in 0.1x PBS) for two hours in a
humidor under room temperature, then the electrodes are washed with 0.1x
PBST for three times and blocked with 0.1 v/v% Triton X-100 for 30 minutes.
0.1 v/v% Triton X-100 is prepared by adding 10 μL of Triton X-100 stock solution
into 10 mL of purified water. BPA (11.3 mg) is dissolved into 5 mL DMSO to
make 10 mM BPA solution, which is then serial diluted to reach concentrations
from 1 fM to 1 pM using 0.1x PBS. The electrodes are then connected to the
impedance analyzer and BPA samples will be introduced to the surface for
testing.
For BPA testing, the test frequency is chosen to be 20 kHz instead of 100
kHz because the whole electrolyte/electrode system is more capacitively
dominant around this specific frequency. Taking SAW electrode as an example,
actual impedance measurement at 20 kHz showed a 𝑅𝑓 of 1879 Ω and a
𝑙

𝐶𝑖𝑛𝑡 of 7.63 nF. Given the dimension of the electrodes, according to 𝑅𝑓 = 𝜎𝐴 ,
where 𝑙 = 𝜋𝑙/2 is the half circle over the electrode gap of 1.1 𝜇𝑚, and A is the
electrode area, 628×150×0.7 𝜇𝑚2 for the whole array; 𝜎=0.15 S/m is the fluid
conductivity. 𝑅𝑓 is estimated to be 1747 Ω for the electrode array. Meanwhile,
according to 𝐶𝑖𝑛𝑡 =

𝜀𝐴
𝑑

, where 𝜀 is the permittivity of the fluid and biomolecule

(𝜀 = 𝜀0 𝜀𝑟 , with 𝜀0 being the permittivity of free space and 𝜀𝑟 being the relative
permittivity of fluid and biomolecule), A is the area (628×150×1.4 𝜇𝑚2 ) and 𝑑
is the thickness of the double layer plus the immobilized biomolecules (around
10 nm), 𝐶𝑖𝑛𝑡 is estimated to be around 9.1 nF. Since both of the theoretical
values are very close to the measured value, a simplified 𝐶𝑖𝑛𝑡 - 𝑅𝑓 serial
connected equivalent circuit can adequately account for the impedance of the
sensor cell, and the measured capacitance can be regarded as Cint.
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6.5.2.1 Proof-of-concept

First of all, as a proof of concept, different concentrations of BPA samples
are tested under 500 mVrms AC signal at 20 kHz for a total of 20 seconds using
SAW electrodes. Figure 6.14 presents how normalized capacitance changes
with time for various sample concentrations. The curve of buffer (black line with
square) remained flat throughout the detection period, showing no occurrence
of biointeraction. For BPA samples ranging from 1 to 1000 fM, the capacitance
change rates become larger with increasing concentrations, manifesting the
increasing level of specific BPA binding. Meanwhile, the curve of non-specific
(100 fM BPA, without aptamer) goes down a little, indicating the existence of
certain level of non-specific binding (red line with circle).
Also, according to Figure 6.14, there are signs of BPA depletion for lower
concentrations after the first 10 seconds of binding, as the curves are gradually
becoming flatter. To demonstrate the binding event with time more accurately,
Table 6.8 lists the change rates at two different time periods: 0-10 seconds and
10-20 seconds. Except for 1000 fM, the change rate in the first 10-second
period is always larger than that in the second 10-second period, as the
depletion of target molecules starts to show as time goes by. In the first 10
seconds, the capacitance change rate of 10 fM BPA quickly reaches
−1.73%/min, which is higher than both of the non-specific (−1.23 %/min) and
buffer control (-0.02 %/min), demonstrating a successful detection.
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Figure 6.14 Characteristic changes of interfacial capacitance with time when
different samples are tested. Binding reactions with 1, 10, 100 and 1000 fM
BPA are shown here. Buffer (blank without BPA) and non-specific (1pM BPA
sample tested on dummy electrodes) are shown as controls.
Table 6.8 Capacitance change rates within two different time periods.
dC/dt (%/min)

0-10s

10-20s

0.1x PBS

-0.02

0.23

Non-specific

-1.23

-0.1

1 fM (0.28 fg/mL)

-0.68

-0.34

10 fM (2.8 fg/mL)

-1.73

-0.08

100 fM (28 fg/mL)

-1.71

-1.1

1 pM (280 fg/mL)

-2.74

-1.12

6.5.2.2 Study of ACET effect

As discussed earlier, the size of small molecules are much tinier compared
with antibodies. From Chapter 4, we see that the relative importance of DEP
and ACET forces will shift in favor of ACET effect with smaller molecules, as
DEP force is dependent on the particle volume while ACET force is not. As a
result, DEP enrichment will be much weaker for BPA than for antibodies. So the
use of ACET effect should be more important to small molecule detection. BPA
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samples from 1 to 100 fM are tested on both SAW and 5μm gold electrodes as
a comparison. The applied electric field strength is very similar, which is 50
mV/μm on SAW electrodes and 46 mV/μm on 5μm electrodes.
Figure 6.15 shows the outputs from both SAW and 5μm gold electrodes. It
can be seen that the rate of decrease in capacitance steadily gets larger with
more concentrated samples on both electrodes. The responses from both
electrodes exhibited a logarithmic dependence on BPA concentration ranging
from 1 to 100 fM. As expected, much larger capacitance change is seen from
5μm gold electrodes, which is clearly the result of stronger ACET convection.
While for SAW electrodes, although the electric field strength is slightly larger,
the response is less obvious than that from 5μm gold electrodes. The detection
sensitivity of 5μm gold electrodes is calculated to be −0.40 ± 0.08 %/log(fM),
much higher than that of SAW electrodes, which is only −0.09 ± 0.04 %/log(fM).

Figure 6.15 BPA detection results on both electrodes. Buffer tests are 0.1x
PBS on functionalized electrodes; non-specific tests are 1-100 fM BPA on
dummy electrodes; specific tests use 1-100 fM BPA samples on functionalized
electrodes. Each data point is the average of three repeated tests and the
error bar indicates standard deviation.
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6.5.2.3 Determination of LOD

From Figure 6.15, we could also determine the limit of detection (LOD) of
the two electrodes. Baseline responses are obtained by measuring buffer,
which are 0.01 ± 0.02 %/min on 5μm gold electrodes and 0.16 ± 0.15 %/min
on SAW electrodes. Besides, responses from non-specific binding are minimal
on both electrodes. 100 fM BPA caused a change rate of −0.10 ± 0.02 %/min
for 5μm electrodes, and 0.01 ± 0.11 %/min for SAW electrodes, showing good
specificity. In comparison, 5μm electrode produces a change rate of −0.50 ±
0.11 %/min for 10 fM BPA, which can easily be distinguished from the baseline.
SAW electrodes yield a change rate of −0.36 ± 0.07 %/min for 100 fM BPA,
which could be also be differentiated. Therefore, LOD is determined to be 10
fM for 5μm electrode and 100 fM for SAW electrodes.
6.5.3 Preliminary detection of PG
Similar to BPA, the detection of progesterone is also categorized as small
molecule detection. Progesterone is very small in size and weight, with a
molecular weight of only 315 Da. Some preliminary experiments are performed
in this work using SAW electrodes.
The experimental procedure is described as follows: cleaned electrodes are
functionalized with anti-PG polyclonal antibody (0.15 μM, diluted in 0.1x PBS)
for two hours in a humidor under room temperature, then the electrodes are
washed with 0.1x PBST for three times and blocked with 0.1x buffer B for 30
minutes. The electrodes are then connected to the impedance analyzer and PG
samples will be loaded for test. PG sample is diluted in 0.1x PBS to get three
different concentrations of progesterone: 0.5ng, 1ng and 5 ng/mL.
An AC signal of 100 mVrms at 100 kHz is applied continuously for one
minute as the measuring signal. Preliminary results with passive adsorption as
surface functionalization method do not show an adequate differentiation, thus
in order to achieve better performance, we also introduce APTES-treated SAW
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electrodes to improve its sensitivity. The procedure of APTEPS treatment has
been described in Chapter 5.
Figure 6.16 shows the preliminary results of spiked PG sample detection.
Three different concentrations of PG are tested consecutively on the same chip,
from low to high. 0 ng/mL means control buffer (0.1x PBS). As could be seen,
binding begins to saturate at 5 ng/mL, since the available binding sites are
limited, capacitance would not change much after the binding starts to saturate.
Furthermore, as expected, chips treated with APTES showed higher
capacitance change compared with bare chips. This could be explained by the
fact that APTES increases the surface availability, i.e. more binding sites are
provided. Although the limit of detection is not increased since the background
also goes higher, the sensitivity is indeed increased with APTES-treated chips.
For APTES-treated chips, sensitivity is about 0.6 %/ (ng/mL), while for bare
chips, sensitivity is only around 0.2 %/ (ng/mL). The limit of detection is
determined to be 1 ng/mL (3.2 nM) for spiked progesterone detection.

Figure 6.16 Detection results of progesterone binding. Different change rates
indicate different binding levels. Each test is repeated three times. Error bar
represents the standard deviation of three test results.
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Chapter 7. Conclusions and Future
Work
7.1 Summary
This work presents an ACEK-based capacitive affinity sensing method that
holds high promise for POC disease diagnosis. The detection is realized
through a capacitive sensing technique with a microelectrode array.
The capacitive affinity sensing technique has two major functions: realizing
the study of nanoscale surface structure and deposition; and carrying out the
detection of specific surface biomolecular interactions. In this work, the first
function is used for surface quality controlling of sensor electrodes, while the
second function is applied to detect specific biomolecular interaction, such as
antigen-antibody binding.
The capacitive assay presented in this work can achieve ACEK enrichment
of biomolecules and label-free detection of deposition on the microelectrode
surface simultaneously. The experiments proved that DEP and ACET effect
could speed up the biointeraction process to achieve rapid and sensitive
detection. Compared with conventional methods, the detection time has been
greatly reduced from hours to minutes.
We also carefully choose our electrode design and detection protocol, so
that at the AC enrichment frequency, the detection cell can be represented with
a simplified resistor-capacitor serial connection (fluid resistance in series with
electrode/fluid interfacial capacitance). Because the effect of sample matrix
mostly shows up in its resistive component (e.g. charge transfer resistance),
the detection method and device combined is relatively unsusceptible to the
interference from the background solution. As a result, this method needs little
pretreatment of the sample (sample pre-treatment requires only volume dilution
of serum samples with physiological buffer), and does not require a washing
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step after binding, which is a major advantage over traditional impedimetric
biosensors.
In summary, the ACEK-based capacitive biosensor has a shorter assay time,
reduced reagent and device cost, simpler device design and operation than
conventional diagnostic system. The potential of this sensing technique for
rapid disease detection might greatly facilitate the battle against the epidemic
of infectious diseases in the future.

7.2 Future Work
7.2.1 Further improvement of feasibility
To build a fully qualified sensing technology for POC diagnosis in real world,
the feasibility of the ACEK-based capacitive sensor needs further improvement.
Compared to electrical signal readout, biological related issues pose more
uncertainties to sensor performance. Surface functionalization is always the
most crucial step in affinity biosensing. In this work, only the effect of 3-MPA is
studied on gold electrodes. Further effort would be focused on the study of
various thiol linker molecules, such as 11-mercaptoundecanioc acid (11-MUA).
Compared with 3-MPA, 11-MUA has longer chains, which is expected to
improve the stability of surface functionalization.
Moreover, the size of the probe molecules could also affect the detected
signal. For example, in progesterone detection, the size of current probe
antibody is much larger than the size of progesterone molecule. The huge size
of probe brings down the detection sensitivity, as the change of capacitance
due to progesterone binding is less notable. Therefore, finding more proper
probe molecules in size for different analytes is one of the tasks of future work.
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7.2.2 Multiplexed assay with high specificity
Multiplexed assay, as opposed to single detection, refers to the detection of
multiple analyte samples simultaneously. It is very useful in real life diagnosis,
as sometimes it is needed to deal with hundreds or thousands of samples within
a short time period. To achieve multiplexed detection, IC integration is needed
to combine several sensors to a single chip, while each sensor should have its
own independent signal source to avoid interference.
7.2.3 Handheld device
The current measurement device is a clumsy benchtop instrument. A
desired prototype for realizing POC diagnosis would be a light, portable and
robust handheld device, as conceptually shown in Figure 7.1. Detection results
could be easily displayed on the screen and can be transferred to a smart phone
if available.

Figure 7.1 Concept of a portable POC device.
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